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Influenza A virus (IAV) is an infectious respiratory pathogen that causes seasonal 
epidemics and sporadic pandemics in human, resulting in tens of thousands of deaths and 
tens of billions of dollars in economic costs every year in the U.S. alone. Its genome 
consists of eight gene segments each encoding one or more viral proteins. The 
expression of all eight genes is required to initiate productive infection. Interestingly, 
under the single particle infection condition, most IAV particles are semi-infectious 
particles (SIPs) that express an incomplete subset of the eight viral genes. The production 
and gene expression pattern of SIPs can vary hugely between IAV strains. However, the 
biological significance of this intrinsic gene expression heterogeneity at single particle 
level remains poorly understood. Here, I aim to investigate that whether and how this 
heterogeneity influences viral superinfection and host innate antiviral response. 
 
To initiate productive infection, multiple SIPs must co-infect one cell to achieve 
complementation. Within a certain MOI range, increasing the abundance of SIPs in a 
viral population increases the percentage of productively infected cells that result from 
co-infection. One of the primary ways by which co-infection can occur is superinfection, 
the sequential infection of one cell by multiple viral particles. However, how SIPs affect 
IAV superinfection remain largely unknown. By combining single particle infection and 
multi-color flow cytometry, I directly assessed the effects of individual IAV genes on 
superinfection efficiency and revealed that superinfection susceptibility is negatively 
correlated with the quantity of viral gene segments expressed within an infected cell, 
regardless of their identity. As a result, cells infected with SIPs are more susceptible to 
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superinfection compared to cells infected with particles that express a complete set of 
viral genes, and viral populations that contain more SIPs undergo more-frequent 
superinfection. Further, I found that viral replicase activity in infected cells is responsible 
for inhibiting the subsequent infection. These findings identify viral gene expression 
heterogeneity as a major determinant of IAV superinfection potential. 
 
Viral infection outcomes are governed by the complex interactions between infecting 
virus population and host response. Although viral gene expression within IAV 
population is extremely heterogeneous, little is known about how this heterogeneity 
influences host response to infection. By pairing Fluorescence-Activated Cell Sorting 
(FACS) with single cell RNA-seq (scRNAseq), I examined the combined host and viral 
transcriptomes of thousands of individual cells, each infected with a single IAV particle. I 
observed complex patterns of viral gene expression and the existence of multiple distinct 
host transcriptional responses to infection at single cell level. In addition, SIPs that fail to 
express the NS gene can play a dominant role in triggering innate anti-viral response to 
infection. Finally, human H1N1 and H3N2 virus infections differ significantly in patterns 
of host anti-viral gene transcriptional at single cell level. These results revealed that how 
patterns of viral gene expression heterogeneity can serve as a major determinant of host 
antiviral gene activation. 
 
Altogether, these studies demonstrate that IAV gene expression heterogeneity has clear 
functional consequences on both viral superinfection potential and host innate response to 
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infection. More broadly, my works help establish the importance of understanding the 
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CHAPTER 1: INTRODUCTION 
1.1 Overview of IAV 
Significance 
Influenza A virus (IAV), together with type B, C, and recently identified type D, belong 
to the Orthomyxoviridae family(Hause et al. 2014). It is an infectious respiratory 
pathogen that causes influenza, also known as “flu”, in birds and a variety of mammals, 
including humans. In most human cases, infections are confined to the upper respiratory 
tract and the symptoms are relatively mild and similar to common cold, including fever, 
runny nose, sore throat, headache, cough, muscle pain and fatigue. However, in some 
severe cases, infections can spread to the lower respiratory tract and the patients can be 
killed by lethal pneumonia due to viral or secondary bacterial infection(Kuiken et al. 
2012). According to the World Health Organization, circulating human IAV strains cause 
annual seasonal epidemics which result in about 1 billion infections, 3 to 5 million 
hospitalizations, and 300000 to 500000 deaths worldwide(Krammer et al. 2018). In 
addition, IAV strains of zoonotic origin can cause sporadic and unpredictable pandemics 
which have happened 4 times over the last 100 years. In 1918, a highly pathogenic IAV 
strain with genes of avian origin caused the “Spanish flu” pandemic, resulting in over 40 
million deaths worldwide. The most recent “swine flu” pandemic occurred in 2009 and 
resulted in more than 150000 deaths worldwide. Results of phylogenetic analysis indicate 
that it was caused by a novel IAV strain with a mixture of avian, swine, and human flu 






The 13 kilobase IAV genome is divided into 8 negative sense, single-stranded RNA 
segments, referred as viral RNAs (vRNA), which encode for 10 essential viral proteins 
and several accessory proteins that are strain-dependent (McGeoch, Fellner, and Newton 
1976). Within virus particles, the 8 vRNA segments are present in the form of viral 
ribonucleoprotein (vRNP) complex, where each vRNA is wrapped around multiple 
copies of viral nucleoprotein (NP), and the semi-complimentary 5’ and 3’ ends base pair 
with each other to form a hairpin structure bound by the viral polymerase heterotrimer, 
consisting of polymerase basic 1 (PB1), polymerase basic 2 (PB2), and polymerase acidic 
(PA) subunits(Hsu et al. 1987; Moeller et al. 2012; Fodor, Seong, and Brownlee 1993; 
Pflug et al. 2014; Arranz et al. 2012). The 8 vRNPs are bundled together to form a “1+7” 
configuration, with 1 central RNP surrounded by 7 other RNPs, and encapsidated within 
a viral protein coat formed by matrix 1 (M1)(Noda et al. 2006). The viral capsid also 
provides support underneath the viral envelope, a host-derived lipid bilayer decorated by 
viral membrane proteins haemagglutinin (HA), neuraminidase (NA), and matrix 2 
(M2)(Gamblin and Skehel 2010; Harris et al. 2006). The size and morphology of 
influenza A particles are highly variable, ranging from spheres of 80 nm in diameter to 
filaments of 20 µm in length(Badham and Rossman 2016). Studies have suggested that 
both viral protein M1 and lipid composition of host membrane at the budding site play 
important roles in determining the morphology of virus particles(Calder et al. 2010; 






IAV strains are classified into different subtypes based on the antigenicity of viral 
glycoproteins HA and NA, the two main targets of the host B cell response(Katz et al. 
2014). Each IAV subtype is characterized by the specific combination of antigenically 
distinct HA and NA. Up to now, 16 antigenically distinct HA (H1-16) and 9 antigenically 
distinct NA (N1-9) have been identified in viruses isolated from wild aquatic birds, which 
serve as the natural reservoir for IAV(Yoon, Webby, and Webster 2014). Besides birds 
and humans, IAV is also capable of circulating in other animal species, such as pigs, bats, 
and horses. These animal reservoirs allow IAV to maintain significant diversity in the 
gene pool of antigenically distinct HA and NA, and the unique ability to adapt to various 
animal hosts makes IAV almost impossible to eradicate(Hurt et al. 2016; Webster et al. 
1992). Recently, 2 additional HA (H17 and H18) and NA (N10 and N11) subtypes have 
been found in influenza A-like viruses isolated from bats(Tong et al. 2012; 2013). 
Despite the numerous possible combinations of HA and NA, only H1N1, H2N2, and 
H3N2 have persisted in humans(Morens, Taubenberger, and Fauci 2009). Among these 3 
subtypes, only H1N1 and H3N2 are currently circulating and therefore are often included 
in the annual flu vaccines(Houser and Subbarao 2015). 
 
Antigenic drift 
Despite the widespread pre-exposure and vaccination, IAV continues to be a major threat 
to global public health, largely due to its ability to constantly evolve and escape pre-
existing humoral immunity(Molinari et al. 2007). One way of evading the antibody-
mediated inhibition is through accumulating point mutations in HA and NA that alter the 
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antigenicity. This mechanism, known as antigenic drift, depends upon the error-prone 
nature of the viral RNA-dependent RNA polymerase (RdRp) that lacks proof-reading 
capability(Drake 1999). The estimated mutation rate of the IAV RdRp is 1.8 to 2.5 × 10-4 
substitutions per nucleotide, resulting in an average of 2 to 3 substitutions in every newly 
synthesized viral genome(Pauly, Procario, and Lauring 2017a). Currently, HA is the main 
component of inactivated flu vaccines, therefore the antigenic drift of HA is most 
extensively studied and constantly monitored to guide vaccine production(Barr et al. 
2014; G. K. Hirst 1943). By pairing computational analysis with site-direct mutagenesis, 
multiple studies have suggested that the epitopes on HA globular head recognized by 
neutralizing antibody exhibit high level of mutational tolerance(Plotkin and Dushoff 
2003; Thyagarajan and Bloom 2014), and one to a few amino acid substitutions in the 
head can lead to significant antigenic drift(Koel et al. 2013). According to surveillance, 
antigenic drift is more evident in circulating seasonal human influenza viruses than in 
animal influenza viruses, possibly due to the longer lifespan of humans(de Jong et al. 
2007; Lewis et al. 2011). Despite being poorly studied, antigenic drift in NA and escape 
mutations in T cell epitopes have been observed and begun to receive increased 
attention(Sandbulte et al. 2011; Voeten et al. 2000). 
  
Antigenic shift 
Another way of developing resistance to pre-existing antibody response is by swapping 
the HA or NA gene between different IAV subtypes, known as antigenic shift(Morens, 
Taubenberger, and Fauci 2009). This process occurs through reassortment, which is the 
exchange of intact gene segments between viruses due to imperfect genome 
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packaging(Lowen 2017). Given reassortment only happens between viruses co-infecting 
the same cell, cellular co-infection of different IAV subtypes is required for antigenic 
shift to occur. Although cross-species transmission is constantly detected in regions 
where human directly contact poultry or swine, the antigenic shift between human and 
animal strains happens less frequently, largely due to the functional incompatibility of 
viral components from different genetic backgrounds(Chengjun Li et al. 2008; 
Greenbaum et al. 2012). However, when antigenic shift happens, the new viruses 
produced will have the potential of causing pandemics in human since most people have 
no pre-existing immunity against them. To date, every influenza virus that has caused a 
major pandemic (except the 1976 H1N1 pandemic) was generated through reassortment 
of human and zoonotic strains(Sobel Leonard et al. 2017). Yet, factors that dictate the 
efficiency of reassortment between different IAV subtypes remain poorly characterized, 
leaving prediction of the next pandemic extremely difficult. 
 
1.2 IAV life cycle 
Binding 
Upon reaching a cell, the receptor-binding site of HA on the viral membrane recognizes 
the terminal sialic acid residues of glycoconjugates on host cell surface(Hamilton, 
Whittaker, and Daniel 2012; Weis et al. 1988). This HA-mediated receptor binding 
process then triggers the internalization of virus particles into host cell via clathrin-
dependent endocytosis or macropinocytosis(Rust et al. 2004; C. Chen and Zhuang 2008). 
It is believed that HAs from avian strains preferentially bind to α-2,3-linked sialic 
acids(Nobusawa et al. 1991), whereas HAs from human strains preferentially bind to α-
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2,6-linked sialic acids(Gambaryan et al. 1997). As a result, the distribution of α-2,3 and 
α-2,6-linked sialic acid receptors in host tissue is considered to be a major determinant of 
host range and tissue tropism of IAV. However, highly pathogenic avian viruses can 
occasionally infect humans despite lacking the airborne transmission between 
hosts(Herfst et al. 2012; Imai et al. 2012; Linster et al. 2014). Multiple studies have also 
revealed that single amino acid substitutions in HAs from avian viruses introduced into 
mammals are enough to alter their receptor binding specificities(M. Matrosovich et al. 
2000). Clearly, the match between HA receptor binding preference and sialic acid linkage 
is not absolute and can easily be altered.  
 
Fusion 
After entering host cell, the virus traffics to endosome where acidification facilitates viral 
genome release. The low pH in endosome first triggers conformational change in HA 
which exposes the fusion peptide on the N-terminus of HA2 subunit(Bullough et al. 
1994). After exposure, the fusion peptide inserts itself into endosomal membrane and the 
HA2 trimers then fold back to create a hairpin that brings viral and endosomal membrane 
in close proximity. Lastly, the hairpin structure collapses into a six-helix bundle to bring 
the two membranes closer, resulting in lipid stalk formation and eventually 
fusion(Harrison 2015; J. M. White and Whittaker 2016). The decrease in endosomal pH 
also leads to proton influx into the viral capsid via M2 ion channel, which weakens the 
interactions between M1 and vRNPs, and facilitates the release of vRNPs into cytosol at 
the membrane fusion site(Pinto and Lamb 2006; Martin and Helenius 1991; Bui, 





Recent studies combining imaging and RNA labeling techniques discovered that from 
attachment to cell surface, IAV can deliver genome into nucleus in as little as 1 
hour(Chou et al. 2013). Timewise, cell entry and fusion can occur within 10 min, whereas 
nuclear import takes up most of the remaining time(Dou et al. 2017). Single-molecule 
FISH-based vRNP tracing revealed that viral genome is released relatively close to the 
nucleus, and the 8 vRNPs are likely to traffic together as a complex before reaching 
nuclear envelope, supporting the observation of high nuclear import efficiency of 8 
vRNPs(Lakdawala et al. 2016). The current model of nuclear import is that the nuclear 
localization signals (NLS) on numerous NP molecules first recruit importin-α, which is 
recognized by importin-β transport receptor. The importin-β then directs the vRNP-
importin-α-importin-β complex to nuclear pore and interacts with pore complex to 
facilitate the entry into the nucleoplasm(P. Wang, Palese, and O’Neill 1997; Wu, 
Weaver, and Panté 2007). In consistent with this model, one study showed that NP of 
avian viruses and mammalian viruses prefer different isoforms of importin-α, indicating 
the importin-α specificity is a determinant of host range and interspecies 
transmission(Gabriel et al. 2011).  
 
vRNA replication 
To initiate vRNA replication, the vRNP-associated viral polymerase first transcribes 
complimentary RNA (cRNA) using vRNA as template. First, 2 free rNTPs base pair with 
the first 2 nucleotides at the 3’ end of vRNA, locking the template to the polymerase 
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active site within the PB1 subunit(Newcomb et al. 2009; York et al. 2013). The 2 rNTPs 
are then ligated into a dinucleotide “primer” to elongate cRNA(Robb et al. 2016). Next, 
the newly synthesized cRNA associates with multiple copies of NP and one copy of 
heterotrimeric viral polymerase to form cRNP. To transcribe vRNA, the cRNP-associated 
viral polymerase using cRNA as template. Like cRNA transcription, the dinucleotide at 
3’ end of cRNA is formed to synthesize vRNA. However, recent structures raise an 
alternative mechanism, that is, the 2 rNTPs base pair with the 4th and 5th base at the 3’ 
end of cRNA to form dinucleotide, and the dinucleotide dissociates and reanneals with 
the 1st and 2nd base(Deng, Vreede, and Brownlee 2006; Jorba et al. 2009; S. Zhang et al. 
2010). In either way, the dinucleotide is positioned at 3’ end of cRNA to initiate vRNA 
elongation, and the synthesized vRNA associates with multiple NPs and one viral 
polymerase trimer to form vRNP.  
 
mRNA transcription 
During infection, viral mRNA transcription starts prior to the unprimed vRNA replication 
and is much more efficient due to priming(Reich et al. 2014). The vRNP-associated viral 
polymerase first acquires capped oligos from host mRNAs to prime transcription, known 
as “cap snatching”(Plotch et al. 1981). This process is mediated by cap-binding domain 
of PB2 that binds to the 5’ caps of nascent host mRNAs(Guilligay et al. 2008), and 
endonuclease domain of PA that cleaves 10 to 13 nucleotides down to the 5’ end(Dias et 
al. 2009). The PB2 then directs the capped primer to the catalytic site of PB1 where it 
gets elongated using vRNA as template. As the polymerase reaches the poly-U sequence 
at the 5’ end of vRNA template, transcription is terminated with polyadenylation through 
9 
 
a “stuttering” mechanism where the elongating 3’ end keeps being repositioned to the 
uracil-rich region(Poon et al. 1999). At last, the newly transcribed viral mRNAs get 
exported into cytoplasm for translation by cellular ribosomes(Jorba et al. 2009). Each 
viral mRNA molecule encodes for one essential viral protein except that M and NS are 
spliced by cellular spliceosomes and encode for M1, M2, non-structural 1 (NS1), and 
nuclear export protein (NEP), respectively(Lamb et al. 1980; Lamb, Lai, and Choppin 
1981; Inglis and Brown 1981). Despite a variance in splicing efficiency among IAV 
strains, it is generally thought that the splice product NEP is equally expressed as NS1, 
whereas the expression of splice product M2 gradually increases as infection goes(Inglis 
and Brown 1984; Valcárcel, Portela, and Ortín 1991; Backström Winquist et al. 2012). 
 
Membrane protein synthesis 
Like secreted cellular proteins, IAV membrane proteins are synthesized by ER-associated 
ribosomes and are eventually decorated onto the plasma membrane from which viral 
envelope originates. The signal recognition particles (SRP) first interact with the 
cleavable ER-targeting signal on HA and the transmembrane domain (TMD) on NA and 
M2. This process targets ribosome-nascent chain complexes (RNC) to the SRP receptors 
in ER membrane(Dou et al. 2014; Daniels et al. 2003). The ribosomes on RNC then 
associate with a protein-conducting channel, or “translocon”, initiating the translocation 
of polypeptide chains into ER lumen(Gilmore, Walter, and Blobel 1982; Görlich et al. 
1992; Bowie 2005). Mutations that alter the hydrophobicity of ER-targeting sequence 
have been shown to modulate the expression level of viral membrane proteins(Nordholm 
et al. 2013). Both HA and NA receive multiple N-linked glycans post-translationally, 
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while the copy number and positioning of glycosylation are strain or subtype-
dependent(Mandon, Trueman, and Gilmore 2013). These glycans recruit lectin 
chaperones and associated oxidoreductase to aid the formation of multiple intramolecular 
disulfide bonds essential to the co-translational folding of HA and NA monomers(N. 
Wang et al. 2008; Hebert et al. 1997). Functionally active HA molecules are formed by 
trimerization of 3 individual monomers, while NA tetramer is formed by pairing 2 co-
translationally dimerized NA monomers(Saito, Taylor, and Webster 1995). During 
infection, significant amount of trimeric HA and tetrameric NA are produced via protein 
concentration-dependent oligomerization, while the tetrameric M2 is formed in much less 
abundance(Holsinger and Lamb 1991). The ratio of HA to NA on viral envelope is 
usually around 4:1, whereas HA to M2 ratio can range from 10:1 to 100:1(Holsinger and 
Lamb 1991; Zebedee and Lamb 1988). It remains largely unclear how IAV regulates the 
timing and expression level of different viral proteins, given the lack of temporal 
variation in viral mRNA transcription(Kawakami et al. 2011). 
 
HA proteolytic activation 
The newly synthesized HA monomer is fusion incompetent precursor HA0 which has to 
be cleaved into HA1 and HA2 subunits to gain fusion capacity prior to being endocytosed 
into infected cells(R. T. Huang, Rott, and Klenk 1981; Maeda, Kawasaki, and Ohnishi 
1981). In HA0 from highly pathogenic avian strains, the multibasic cleavage sites are 
cleaved by furin, a ubiquitously expressed, calcium-dependent serine endoprotease that 
resides within trans-Golgi network(Böttcher-Friebertshäuser et al. 2014; Stieneke-Gröber 
et al. 1992). Whereas in HA0 from human strains, the monobasic cleavage site is cleaved 
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by proteases in human respiratory epithelial cells, including human airway trypsin-like 
protease (HAT) and transmembrane protease serine S-1 member 2 (TMPRSS2)(Böttcher 
et al. 2006). HAT is mainly found at plasma membrane of epithelial cells in upper 
respiratory tract, where it cleaves both membrane-associated HA and HA in virus 
particles attaching to the cells(Zhirnov, Ikizler, and Wright 2002). TMPRSS2 is present 
in trans-Golgi network of epithelial cells in both upper and lower respiratory tract, where 
it only cleaves HA trafficking towards the membrane(Bertram et al. 2012). 
 
RNP assembly 
Besides the 3 membrane proteins, the other 7 essential viral proteins, PB1, PB2, PA, NP, 
M1, NS1, and NEP are translated by cytosolic ribosomes and imported back into the 
nucleus(York and Fodor 2013). Using the same mechanism that vRNP nuclear import 
utilizes, PB2 and NP are imported individually, whereas PB1 and PA are imported as 
heterodimer(Cros, García-Sastre, and Palese 2005). Within the nucleus, NP monomers 
oligomerize and bind to the 12 nucleotide stretches of newly synthesized vRNA or 
cRNA(Lee et al. 2017). This NP-RNA association is likely regulated by NP 
phosphorylation(Mondal et al. 2015). The PB2 associates with dimerized PB1 and PA to 
form viral polymerase heterotrimer which binds to the hairpin structure of NP-associated 
vRNA or cRNA to finalize the vRNP or cRNP assembly. The M1 is likely an adaptor 
protein that links vRNPs to NEP which targets vRNPs to cellular exportin-1-dependent 
nuclear export pathway, as well as a blocker that covers NLS in NP to prevent re-import 
of vRNPs exported to cytoplasm(Shimizu et al. 2011; Akarsu et al. 2003; S. Huang et al. 
2013). The last essential viral protein out of the 7 is the viral RNA-binding protein NS1, 
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which is produced and imported into nucleus during early stage of infection to inhibit 
host interferon signaling and link viral mRNAs with cellular nuclear export factors to 




Previous studies proposed that PB2 of cytoplasmic vRNPs associate with Rab11 on 
recycling endosomes and traffic towards plasma membrane along with 
microtubules(Amorim et al. 2011, 11; Momose et al. 2011), whereas recently an 
alternative model proposed that vRNPs bind to Rab11 close to ER network that 
undergoes tubulation caused by infection to travel towards cell surface(de Castro Martin 
et al. 2017). Cross section images of budding virus particles revealed that most viral 
genomes share a common pattern of 7 vRNPs surrounding 1 central vRNP, known as the 
“7+1” array, which likely depends upon physical interactions of individual vRNP 
segments(Noda et al. 2006; Sugita et al. 2013; Fournier et al. 2012; Gavazzi et al. 2013; 
Noda et al. 2012). These interactions likely occur after nuclear export of vRNPs and prior 
to budding, but the exact location where they happen remains unknown. Numerous 
studies have shown that the 5’ and 3’ UTRs together with terminal coding regions of the 
vRNA, known as “packaging signal”, are required for the highly selective and efficient 
packaging of 8 vRNPs(Hutchinson et al. 2010; Fujii et al. 2003). Recently, a study 
indicated that viral promoter and non-coding regions are crucial for the packaging of each 
individual vRNP segment, while the terminus of segment-specific coding regions are 
responsible for selective packaging of the full set of 8 distinct vRNP segments(Goto et al. 
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2013). Outside of the canonical packaging signal, sequence elements within internal 
coding region are also suggested to contribute to maximizing the packaging 
efficiency(Williams et al. 2018). 
 
Budding  
The envelopes of virus particles are enriched with cholesterol and sphingolipids, 
suggesting the viral budding occurs in lipid rafts of apical plasma membrane(Lingwood 
and Simons 2010). The HA concentrates in lipid rafts due to the fatty acid modifications 
on C-terminal cysteine(Takeda et al. 2003; Zurcher, Luo, and Palese 1994; Kordyukova 
et al. 2008), and the NA enrichment at budding site is attributed to the C-terminus of the 
TMD(Barman et al. 2004). The M1 in cytoplasm has been proposed to be recruited to the 
budding region by associating with cytoplasmic tails of HA and NA(Ali et al. 2000). 
Upon reaching the plasma membrane, M1 oligomerizes underneath to form viral capsid 
layer and the vRNPs are thought to directly bind to M1 to ensure encapsidation(J. Zhang, 
Pekosz, and Lamb 2000; Noton et al. 2007). Expression of HA and NA in lipid rafts 
alone can induce positive membrane curvature and budding(B. J. Chen et al. 2007; Lai et 
al. 2010; Yondola et al. 2011; Chlanda et al. 2015), whereas the oligomerized M1 is 
likely to also significantly curve the membrane which provides an explanation for its role 
in determining the shapes of budding virus particles(Elleman and Barclay 2004). The 
other membrane protein M2 is found to locate at the boundary of the budding region and 
incorporate the hydrophobic face of its cytoplasmic amphipathic α-helix into membrane 
leaflet to generate negative membrane curvature, which potentially brings the opposing 
membranes of the budding neck closer to each other and eventually results in 
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scission(Rossman et al. 2010; Rossman and Lamb 2013). Although many details of the 
budding process remain unknown, it seems that IAV uses multiple viral proteins to 
induce membrane curvature and facilitate viral budding through a combination of cone-
shaped lipids recruitment, membrane-bending protein association, and molecular 
crowding on membrane leaflet. 
 
Cell release  
The release of virus particles that bud out of host cell surface is mediated by sialidase 
activity of NA which hydrolyzes glycosidic bond attaching the terminal sialic acids to 
sugar molecules underneath(Burnet 1948; Burnet, Mccrea, and Anderson 1947). By 
cleaving the sialic acids, NA prevents HA from binding to cell surface and facilitates 
viral release(Webster and Laver 1967). Since both HA and NA are glycosylated, NA has 
also been shown to cleave sialic acids on N-linked glycans from HA and NA in the viral 
envelopes which promotes separation of virus particles and inhibits viral 
aggregation(Palese et al. 1974).  
 
Post-release movement 
After being released from cell surface, virus particles not only move through the mucus 
layer rich in heavily glycosylated mucins and infect nearby naïve cells to promote within-
host transmission, but also make their way towards the luminal side of mucus and get 
exhaled into the air via aerosols or droplets to facilitate inter-host transmission(Kutter et 
al. 2018). Upon entering a new host, virus particles penetrate mucus layer at the 
inoculation site to reach the epithelial cells underneath and initiate infection. Studies have 
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shown that NA-mediated sialic acid cleavage releases viruses from mucins covered with 
sialylated O-linked glycans, thereby enhancing the viral movement through mucus(Cohen 
et al. 2013). As a result, decrease in NA activity in the presence of mucus inhibits both 
viral infection and transmission(Zanin et al. 2015; M. N. Matrosovich et al. 2004). Unlike 
HA, NA from human IAV strains prefer to cleave α-2,3 linked sialic acids compared with 
α-2,6-linked sialic acids(Air 2012; Mochalova et al. 2007). The sialic acid preference of a 
particular viral HA-NA combination, as well as the host sialic acid profile at the infection 
site, largely dictate the receptor-binding affinity of HA and the receptor-cleaving activity 
of NA, therefore governing tissue tropism, host range, viral fitness and transmissibility of 
IAV(de Vries et al. 2020). 
 
1.3 IAV gene expression heterogeneity 
Definition 
Although the expression of 10 functional essential viral proteins encoded by 8 viral gene 
segments is required for productive infection, most IAV particles fail to express at least 
one functional essential viral protein under single-particle infection condition(Brooke et 
al. 2013). It has been shown that 70% to 99% of virus particles across different IAV 
strains are unable to initiate productive infection and cannot be detected using plaque 
assay, a commonly used technique to measure viral titer(Donald and Isaacs 1954). 
Instead, they can be detected through hemagglutination assay or real-time PCR that 
quantifies total physical virus particles and genome equivalents, respectively. These 
“non-infectious” particles, the silent majority of viral populations, consist of defective-
interfering particles (DIPs) and semi-infectious particles (SIPs)(Nayak, Chambers, and 
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Akkina 1985; Heldt et al. 2015; Brooke 2014). DIPs are characterized as viruses with one 
or more gene segments harboring large internal deletion which encode for short, non-
functional viral gene products. DIPs can only propagate under high MOI condition where 
they can be complemented by other co-infecting viruses(Von Magnus 1951). In contrast 
with DIPs, SIPs lack a unique molecular signature. They refer to viruses that encode for 
incomplete, variable subset of the 10 functional essential viral proteins. SIPs are 
constantly produced during viral infection which makes them the dominant virion type in 
most viral populations(Brooke 2017). Like DIPs, SIPs cannot initiate productive infection 
by themselves. They must complement each other during high MOI co-infection to avoid 
becoming dead-end products. In this thesis, IAV gene expression heterogeneity is defined 
as variation in gene coding capacity of individual virions.  
 
Origins 
IAV gene expression heterogeneity arises from a variety of mechanisms that are not 
mutually exclusive. Results from EM imaging analysis revealed that up to 20% of virus 
particles contain less than 8 gene segments(Nakatsu et al. 2016). In addition, it has been 
shown that IAV can package host ribosomal RNA into virus particles to complete the 
“7+1” array(Noda et al. 2018). Therefore, despite being highly selective and efficient, 
IAV genome packaging is imperfect which can lead to failure in delivery of 8 distinct 
viral gene segments into infected cells. Numerous studies have indicated that the viral 
genome trafficking and nuclear import are also imperfect(Babcock, Chen, and Zhuang 
2004; Schelker et al. 2016). The viral genome in cytoplasm is constantly at risk of being 
degraded before reaching nuclear envelope, while the interferon inducible antiviral factor 
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myxovirus resistance 1 (Mx1) may actively interfere with the nuclear import(Chou et al. 
2013; Götz et al. 2016). As a result, it is highly likely that not all gene segments packaged 
into virus particles are successfully imported into nucleus. Further, random mutations in 
critical regulatory elements and coding regions of viral genes may hinder transcription 
and result in truncation or mis-folding of viral proteins(Pauly, Procario, and Lauring 
2017b). Importantly, it is possible that a perfectly packaged virus without any lethal 
mutations may still end up being a SIP due to random failure of replication 
steps(Diefenbacher, Sun, and Brooke 2018). Together, through imperfect packaging, 
lethal mutations, and failure of trafficking, nuclear import, transcription and translation, 
IAV populations maintain a significant amount of heterogeneity in viral gene coding 
capacity at single particle level. 
 
Phenotypic effects 
Viral gene expression heterogeneity is observed not only in cell culture, but also in 
animals infected with lab-adapted or clinical IAV strains(Nakatsu et al. 2016; Brooke et 
al. 2014). Interestingly, the quantity and composition of SIPs produced by different IAV 
strains can vary hugely(Brooke et al. 2013). The gene expression profile of a given viral 
population is likely governed by a combination of viral genotype, host cell environment, 
and stochastic events during infection. Low dose UV irradiation of virus decreases the 
average gene expression frequency and artificially increases SIPs content. It has been 
shown that increasing the fraction of SIPs increases reassortment frequency by promoting 
co-infection, suggesting SIPs may facilitate viral evolution(Fonville et al. 2015). 
Recently, a study showed that a single amino acid substitution in NP selectively decrease 
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NA segment abundance and packaging rate, increasing the fraction of SIPs that do not 
express NA. The stoichiometric decrease of NA segment in a viral population decreases 
the relative expression level of NA in multiply infected cells, suggesting SIPs may 
regulate viral gene expression through gene dosing effects(Brooke et al. 2014). Despite a 
lot still being unknown, it is clear that IAV gene expression heterogeneity can have 
significant functional consequences and SIPs are not merely byproducts resulting from 
unavoidable errors of infection. 
 
1.4 IAV collective interactions 
Co-infection and superinfection 
Co-infection occurs when one cell is infected by multiple virus particles. Studies have 
shown that under multi-round replication, co-infected cells are detected with high 
frequency in IAV-infected mice and guinea pigs(Brooke et al. 2014; Fukuyama et al. 
2015). Since co-infection mediates reassortment and facilitates productive infection of 
SIPs through complementation, the co-infection frequency could be a major determinant 
of viral replicative and evolutionary potential(George K. Hirst 1973). Further, co-
infection frequency governs the average copy number of viral genomes delivered into 
each infected cell which has been suggested to play important roles in viral replication 
dynamics and interferon induction(Phipps et al. 2020). In nature, not all infections 
happen simultaneously, and it is likely that a sizable proportion of co-infected cells result 
from multiple sequential infections. The subsequent infection of cells that are already 
infected is known as superinfection. The key signature of superinfection is that when it 
happens to the infected cells, the primary virus has already initiated replication. Like 
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many other enveloped viruses, IAV has been shown to potently and rapidly inhibit 
superinfection, a phenomenon known as superinfection exclusion (SIE)(I.-C. Huang et al. 
2008). However, the existence of potent universal SIE is at odds with the observations of 
frequent co-infection and wide-spread reassortment from numerous studies(Brooke et al. 
2014; Rambaut et al. 2008; Nelson et al. 2008). Thus, defining the mechanism of SIE is 
important for better understanding the collective interactions of IAV. 
 
Reassortment 
Reassortment is the biological process that multiple distinct viruses co-infect the same 
cell and exchange one or more viral gene segments to generate progeny with novel 
genotypes. As homologous recombination seems to be extremely rare, reassortment 
serves as the primary mechanism of genetic recombination for IAV(Boni et al. 2008). 
Reassortment occurs frequently between compatible strains in cell culture, laboratory 
animals, and wild birds, with little bias towards certain combinations of gene segment 
variants(Tao, Steel, and Lowen 2014; Tao H et al. 2015; Dugan et al. 2008). 
Sporadically, reassortment can occur between human and zoonotic strains which has been 
responsible for causing all major flu pandemics over the past century. Reassortment 
between some IAV strains can be inhibited or limited to only produce specific genotypes, 
possibly due to incompatibility of packaging signals or viral proteins(Phipps et al. 2017; 
White MC et al. 2017; Essere et al. 2013). To date, how frequent reassortment occurs 
during human infections remains largely unclear(Leonard et al. 2017). Recently, multiple 
studies showed that reassortment within single viral populations occurs with high 
frequency and without restrictions, allowing the reshuffling of gene segments with 
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beneficial or deleterious mutations(Marshall et al. 2013; Murcia et al. 2010). Therefore, 
reassortment without segment mismatch may serve as an adaptation driving force that 
optimizes fitness of the viral populations by combining beneficial alleles and purging 
deleterious alleles. Together, reassortment within a viral population and between viral 
populations both generate enormous genotypic diversity that fuels rapid viral evolution, 
promoting optimization of viral fitness, adaptation to new hosts, and evasion of host 
immune responses(Steel and Lowen 2014). 
 
1.5 Interactions of IAV and host innate immune response  
Overview of host innate immune response  
The innate immune responses serve as the first line of defense against IAV infection. 
Mucus forms a physical barrier rich in mucins and collectins that can trap the virus 
particles and stopping them from reaching the epithelial cells underneath. Once the 
infection initiates, the pathogen recognition receptors (PRRs) in infected cells recognize 
pathogen-associate molecular patterns (PAMPs) produced by the virus, triggering 
signaling cascades that result in production of cytokines and type I/III interferons 
(IFNs)(Iwasaki and Pillai 2014). Among all the PRRs, toll-like receptors (TLRs), retinoic 
acid inducible gene-I (RIG-I)-like receptors (RLRs), and nucleotide oligomerization 
domain (NOD)-like receptors (NLRs) are involved in recognizing IAV infection and 
inducing IFNs(Blasius and Beutler 2010; Takeuchi and Akira 2009; Pang and Iwasaki 
2011). IFN secretion eventually leads to expression of interferon-stimulated genes (ISGs) 
in infected and neighboring cells, which in turn inhibits viral replication and spread. 
Importantly, the activation of innate immune responses also contributes to initiation of 
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adaptive immune responses responsible for the viral clearance, whereas excessive 
inflammatory responses induced by highly pathogenic IAV strains can be detrimental and 
sometimes fatal to the host. 
 
Recognition by TLRs 
TLR3 and TLR7 are both expressed on the inside of cellular endosomes and recognize 
endosomal viral RNA. Upon IAV infection, TLR3 recognizes unidentified double 
stranded (ds) RNA species in human respiratory epithelial cells while TLR7 recognizes 
single stranded (ss) RNA genomes within virions in the endosomes(Alexopoulou et al. 
2001; Diebold et al. 2004). Upon activation of TLR3 signals, TLR3 interacts with the 
adaptor TIR domain-containing adaptor inducing IFN-β (TRIF) in human respiratory 
epithelial cells, macrophages and dendritic cells, and TRIF activates the TRAF family 
member-associated NF-κB activator (TANK)-binding kinase-1 (TBK1) and inhibitor of 
κB kinase ε (IKKε), leading to phosphorylation of interferon regulatory factor 3 (IRF3) 
and induction of type I IFNs(Chengye Li et al. 2020). The TLR3 activation induces 
antiviral state to restrict viral replication but also recruits inflammatory cells that can 
cause damage to the hosts. It has been shown that TLR3-/- mice have increased viral loads 
in the lungs but survive longer than wild-type mice upon challenge of lethal dose IAV(Le 
Goffic et al. 2006). Upon activation of TLR7 signals, TLR7 interacts with adaptor 
myeloid differentiation factor-88 (MyD88) to activate IRF7 via IKKα, leading to 
expression of IL-6 and type III IFNs in bronchial epithelial cells and type I IFNs in 
plasmacytoid dendritic cells (pDCs)(Honda et al. 2005). TLR7 activation induces 
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production of IFNs and pro-inflammatory cytokines and plays important roles in 
promoting antibody responses upon sublethal IAV infection(Jeisy-Scott et al. 2012, 7). 
 
Recognition by RLRs 
The RLR family consists of RIG-I, melanoma differentiation-associated gene 5 (MDA5) 
and laboratory of genetics and physiology 2 (LGP2), which recognize replicating viral 
RNA in the cytosol. Among them, RIG-I is the most well-studied IAV sensor that 
recognizes cytosolic dsRNA and 5’-triphosphate containing ssRNA generated from viral 
replication in infected epithelial cells, conventional DCs and alveolar 
macrophages(Pichlmair et al. 2006; Kato et al. 2005). After viral RNA recognition by the 
carboxy-terminal domain, the helicase domain of RIG-I binds to ATP and exposes the 
caspase-recruitment domains (CARD). The exposed CARD domains are then 
ubiquitinated by E3 ligases TRIM25 which results in interactions of RIG-I and 
mitochondrial antiviral signaling adaptor (MAVS)(Kowalinski et al. 2011; Luo et al. 
2011). MAVS can recruit TNF-receptor-associated factor 6 (TRAF6), receptor-
interacting protein (RIP)1, NF-κB essential modulator (NEMO), TAK1, IKKα and IKKβ 
to activate NF-κB which leads to the production of pro-inflammatory cytokines. In 
addition, MAVS can also recruit TRAF3, TANK, TBK1, and IKKε to activate IRF3 
which leads to the production of type I IFNs(Chengye Li et al. 2020).  
 
Antiviral activity of ISGs  
After being secreted, the type I (IFNα and IFNβ) and III (IFNλ) IFNs bind to their 
receptors on the same cell or surrounding cells. The receptor binding activates Janus 
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protein tyrosine kinase 1 (JAK1) and tyrosine kinase 2 (TYK2) which leads to 
phosphorylation of the signal transducer and activator of transcription 1 (STAT1) and 
STAT2 transcription factors(Levy, Marié, and Durbin 2011). The phosphorylated STAT1 
and STAT2 then associate with IRF9 to form the heterotrimeric ISG factor 3 (ISGF3) 
complex which enters the nucleus and binds to IFN-stimulated response elements 
(ISREs) within the promoter regions of ISGs to promote their transcription(Hoffmann, 
Schneider, and Rice 2015). Many ISGs induced by IAV infection have been shown to 
limit viral replication through a variety of mechanisms. The human Mx1 binds to viral 
NP in the cytosol to inhibit viral transcription, while interferon-induced transmembrane 
protein 1 (IFITM1), IFITM2, and IFITM3 have been shown to inhibit fusion of viral and 
endosomal membrane(Turan et al. 2004; Bailey et al. 2014). Protein kinase R (PKR) 
promotes type I IFN production by stabilizing their mRNA(Schulz et al. 2010). It also 
inhibits viral protein synthesis by phosphorylating α subunit of eukaryotic initiation 
factor 2 (eIF2α) and activates NF-κB by phosphorylating its inhibitor IκB(Kumar et al. 
1994; Patel and Sen 1998). 
 
Inhibition of innate immune response by NS1 
 
The viral protein NS1 encoded by NS segment suppresses host innate immune response 
to ensure efficient viral replication(Klemm et al. 2018). It has been shown that IAV with 
decreased NS1 expression or expressing malfunctional NS1 are highly attenuated when 
replicating in cells capable of producing type I IFN(Talon, Salvatore, et al. 2000; Nogales 
et al. 2014). Numerous studies have demonstrated that NS1 interferes with the function of 
many cellular proteins involved in different pathways of innate immune response to 
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infection. NS1 suppresses IFN production by directly interacting with TRIM25 to inhibit 
the activation of RIG-I and inhibiting the activity of transcription factors IRF3 and NF-
κB(Gack et al. 2009; Talon, Horvath, et al. 2000; X. Wang et al. 2000). Additionally, 
NS1 binds to dsRNA to inhibit the activation 2’-5’ oligoadenylate synthetase (OAS)-
ribonuclease L (RNaseL) which degrades viral ssRNA(Min and Krug 2006). Moreover, 
NS1 inhibits activity of PKR by direct interactions and sequestration of dsRNA(S. Li et 
al. 2006). Finally, NS1 in some IAV strains have been reported to interfere with 
maturation, polyadenylation, and nuclear export of host mRNA, resulting in shutoff of 
host protein synthesis(Satterly et al. 2007; Noah, Twu, and Krug 2003; Z. Chen, Li, and 
Krug 1999).  
 
1.6 Aims of this thesis 
IAV gene expression is extremely heterogeneous, and the biological significance of this 
heterogeneity is desperately in need of further investigation. Due to this heterogeneity, 
the dominant constituent of IAV populations are SIPs which require co-infection and 
complementation to initiate productive infection. Reassortment is one of the major 
mechanisms that facilitate IAV evolution and can only occur in cells co-infected by 
multiple distinct viruses. Therefore, co-infection rate is a major determinant of IAV 
replicative and evolutionary potential. One of the primary mechanisms by which co-
infection can happen is superinfection, the sequential infections of one cell by multiple 
viruses. Huang et al. demonstrated that NA activity is necessary and sufficient to potently 
inhibit IAV superinfection by removing SA-containing receptors on surface of infected 
cells(I.-C. Huang et al. 2008). In support of this finding, Dou et al. recently reported a 
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narrow time window of 3 hours during which superinfection can occur(Dou et al. 2017). 
However, Marshall et al. showed that superinfection occurs up to 8 hours after the 
primary infection and results in robust co-infection and reassortment(Marshall et al. 
2013). Further, multiple studies showed that co-infection and complementation are quite 
common in respiratory tracts of IAV-infected mice and guinea pigs(Brooke et al. 2014; 
Fukuyama et al. 2015). Together, factors that dictate IAV superinfection potential remain 
to be characterized. 
 
In this thesis, I investigated how gene expression heterogeneity influences IAV 
superinfection potential (chapter 2). By combining single particle infection and multi-
color flow cytometry, I directly quantified superinfection efficiency in infected cells that 
express different combinations of viral genes. The results showed that superinfection 
susceptibility is negatively correlated with the quantity of viral gene segments expressed 
within an infected cell, regardless of their identity. In addition, cells infected with SIPs 
are more susceptible to superinfection compared to cells infected with particles that 
express a complete set of viral genes, and viral populations that contain more SIPs 
undergo more-frequent superinfection. Further, I found that viral replicase activity in 
infected cells is responsible for inhibiting the subsequent infection. These findings raise a 
novel mechanism of superinfection exclusion and identify viral gene expression 
heterogeneity as a major determinant of IAV superinfection potential. 
 
Besides viral gene expression heterogeneity, I also tried to define other factors that 
govern IAV superinfection potential (chapter 3). Specifically, I found that superinfection 
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potential decrease with increase of MOI of the primary infection. In addition, IAV 
superinfection exclusion is largely independent of host innate immune response and is 
likely to occur post viral binding. These findings validate previous results and shed new 
light on mechanisms of IAV superinfection exclusion. 
 
Under low MOI condition where most infected cells are infected with single virus 
particles, viral gene expression patterns vary significantly between individual infected 
cells due to the existence of extreme gene expression heterogeneity within IAV 
populations. Thus, the overall infection outcome is likely governed by the complex 
interplay of viral heterogeneity and host response at single cell level. Due to the technical 
challenge, most studies on host response to IAV infection remain at bulk level which 
masks the cell-to-cell heterogeneity in both viral and host gene expression. Several 
studies have taken advantage of the recent progress in single cell RNA sequencing 
(scRNAseq) technique to characterize single cell heterogeneity during IAV 
infection(Heldt et al. 2015; Russell, Trapnell, and Bloom 2018; Russell et al. 2019). 
However, these efforts are more or less hampered by the limited number of cells analyzed 
or experimental set up that confounded the results. How patterns of single cell 
heterogeneity in IAV-infected cells shape infection dynamics and viral pathogenesis 
remain poorly understood. 
 
In this thesis, I investigated how viral gene expression heterogeneity influences host 
innate antiviral response to IAV infection (chapter 4). By pairing Fluorescence-Activated 
Cell Sorting (FACS) with single scRNAseq, I examined the combined host and viral 
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transcriptomes of thousands of individual cells, each infected with a single IAV particle. 
Even under the condition where viral input and infection time are largely equivalent for 
all infected cells, I observed complex patterns of viral gene expression and the existence 
of multiple distinct host transcriptional responses to infection at single cell level. In 
addition, I found that SIPs that fail to express the NS gene can play a dominant role in 
triggering innate anti-viral response to infection. Finally, human H1N1 and H3N2 virus 
infections differ significantly in patterns of host anti-viral gene transcriptional at single 
cell level. These results reveal how patterns of viral gene expression heterogeneity can 




























CHAPTER 2: IAV GENE EXPRESSION HETEROGENEITY REGULATES 
VIRAL SUPERINFECTION POTENTIAL 
 
2.1 Introduction 
Influenza A virus (IAV) is estimated to cause hundreds of thousands of deaths across the 
world every year during seasonal epidemics, despite widespread preexposure and 
vaccination(Iuliano et al. 2018). In addition to the yearly burden of seasonal influenza 
viruses, novel zoonotic IAV strains periodically emerge into humans from swine or birds, 
triggering unpredictable pandemics that can dramatically increase infection and mortality 
rates(Taubenberger and Morens 2010). Defining the specific factors that influence the 
evolution of influenza viruses is critical for designing more-effective vaccines, 
therapeutics, and surveillance strategies. 
 
The prevalence of coinfection can play an enormous role in determining the replicative 
and evolutionary potential of IAV populations. This is a function of both the segmented 
nature of the viral genome and the enormous amount of genomic heterogeneity present 
within IAV populations(Brooke 2014; 2017). Coinfection allows reassortment, i.e., the 
production of novel viral genotypes through the intermixing of the individual IAV 
genome segments(Lowen 2017; McDonald et al. 2016). Reassortment events have 
contributed to the emergence of every major influenza pandemic of the past 
century(Taubenberger and Kash 2010). Coinfection also facilitates the complementation 
and productive replication of the semi-infectious particles (SIPs) that make up the 
majority of IAV populations(Brooke et al. 2013; 2014; George K. Hirst 1973; Russell, 
Trapnell, and Bloom 2018; George K. Hirst and Pons 1973). Finally, increasing the 
frequency of coinfection can accelerate viral replication kinetics and virus output by 
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increasing the average multiplicity of infection (MOI)(Dou et al. 2017; D. O. White and 
Cheyne 1966; D. White et al. 1965). Thus, to better understand how IAV populations 
transmit and evolve, we must identify the specific host and viral factors that govern 
coinfection. 
 
One of the primary means by which coinfection can occur is superinfection, the 
sequential infection of one cell by multiple viral particles. For some viruses, 
superinfection appears to occur freely(Ramig 1990; Keirstead and Coombs 1998). In 
contrast, a diverse range of viruses actively inhibit superinfection through a variety of 
mechanisms, a phenomenon known as superinfection exclusion (SIE)(Nethe, Berkhout, 
and van der Kuyl 2005; Schaller et al. 2007; Tscherne et al. 2007; Zou et al. 2009; X.-F. 
Zhang et al. 2017; Laliberte and Moss 2014; Folimonova 2012; Simon et al. 1990; 
Ludlow et al. 2005). The only in-depth study of IAV superinfection performed to date 
concluded that the viral neuraminidase (NA) protein acts to potently and rapidly inhibit 
IAV superinfection by depleting infected cells of the sialic acid receptors required for 
viral entry(I.-C. Huang et al. 2008). More recently, Dou et al. reported a narrow time 
window during which IAV superinfection was possible(Dou et al. 2017). These findings 
are consistent with recent studies that have argued that reassortment is rare during human 
infection(Leonard et al. 2017; Xue et al. 2017). However, the existence of a potent 
mechanism of IAV SIE is at odds with both the frequent coinfection observed in a variety 
of experimental settings and the widespread occurrence of reassortment at the global 
scale(Rambaut et al. 2008; “Multiple Reassortment Events in the Evolutionary History of 
H1N1 Influenza A Virus Since 1918” n.d.; Holmes et al. 2005; Nelson et al. 2008; 
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Westgeest et al. 2014; Maljkovic Berry et al. 2016). Marshall et al. showed that 
superinfection occurring at up to 8 h after a primary infection leads to robust coinfection 
and reassortment in cell culture(Marshall et al. 2013). Extensive coinfection and 
complementation have also been observed in the respiratory tracts of IAV-infected mice 
and guinea pigs(Brooke et al. 2014; Fukuyama et al. 2015). Collectively, these results 
suggest that IAV superinfection can be restricted, but to what extent and through which 
specific mechanisms remain crucial open issues. 
 
Here, we reveal that IAV superinfection potential is regulated by the extent of genomic 
heterogeneity within the viral population. We observed that superinfection susceptibility 
is influenced in a dose-dependent fashion by the number of viral genes expressed by the 
initially infecting virion. Further, we show that superinfection occurs more frequently in 
IAV populations with more SIPs than in those with fewer. Finally, we demonstrate that 
SIE is mediated by the presence of active viral replication complexes and is completely 
independent of the gene coding sequence. Taken together, our results reveal how 
genomic heterogeneity influences IAV superinfection potential and demonstrate how 
SIPs can modulate collective interactions within viral populations. 
 
2.2 Results 
Influenza virus SIE occurs in multiple cell types and is independent of type I 
interferon (IFN) secretion 
A previous study of IAV SIE concluded that NA expression completely blocks 
susceptibility to superinfection by 6 h post-infection (hpi)(I.-C. Huang et al. 2008). To 
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explore the potential mechanisms of IAV SIE in greater detail, we developed a flow 
cytometry-based assay that allows us to precisely measure the effects of previous 
infection on superinfection efficiency. To clearly identify cells infected by the first virus 
or by the superinfecting virus or by both, we used two recombinant viruses that express 
antigenically distinct hemagglutinin (HA), NA, and NS1 proteins that we could 
distinguish using specific monoclonal antibodies (MAbs) that we had on hand (Fig. 2.6). 
For the primary infection, we used a recombinant version of H1N1 strain A/Puerto 
Rico/8/34 (rPR8). For the secondary infection, we used a recombinant virus (rH3N2) that 
contained the HA and NA gene segments from H3N2 strain A/Udorn/72, the NS gene 
segment from A/California/04/09, and the remaining 5 segments from PR8. 
 
We first asked whether prior infection with rPR8 affected cellular susceptibility to 
superinfection with rH3N2. We infected Madin-Darby canine kidney (MDCK) cells with 
rPR8 at an MOI of <0.3 50% tissue culture infective doses (TCID50)/cell, and at 3 hpi (all 
times post-infection are expressed relative to the time at which the first virus was added) 
we added the PR8-HA-specific neutralizing MAb H17-L2 to block secondary spread of 
rPR8 within the culture. At 6 hpi, we infected with rH3N2 at a MOI of <0.3 TCID50/cell 
(6 hr). To prevent spread of both rPR8 and rH3N2, we added 20 mM NH4Cl at 9 
hpi(Martin and Helenius 1991; Ohkuma and Poole 1978). In parallel, we performed 
simultaneous coinfections (0 hr) with rPR8 and rH3N2 to measure coinfection 
frequencies under conditions SIE should not be possible. At 19 hpi, we harvested cells 
and examined primary and secondary virus infections by flow cytometry, using H1 
expression and H3 expression as markers of rPR8 infection and rH3N2 infection, 
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respectively. We observed that the H3-positive (H3+) frequency within H1+ cells was 
significantly reduced when rPR8 infection preceded rH3N2 by 6 h compared with when 
rPR8 and rH3N2 were added simultaneously (Fig. 2.1A). This indicated that rPR8 
infection significantly reduces the susceptibility of cells to superinfection by 6 hpi. 
 
We next asked whether the SIE effect was cell type specific and whether it depended on 
activation of the type I interferon (IFN) system. We performed the experiment described 
above in MDCK cells, A549 cells, human embryonic kidney HEK293T (293T), and Vero 
cells (which are incapable of type I IFN secretion)(Desmyter, Melnick, and Rawls 1968; 
Emeny and Morgan 1979). We observed that the levels of SIE were comparable among 
all cell lines tested, suggesting that SIE occurs in multiple distinct cell types and does not 
depend upon IFN secretion (Fig. 2.1B,2.7). 
 
SIE does not depend upon viral neuraminidase activity 
In an attempt to confirm the previously reported role for NA activity in SIE, we directly 
measured the effect of NA expression on SIE in our system(I.-C. Huang et al. 2008). We 
took advantage of our previous observation that IAV populations consist primarily of 
SIPs that fail to express one or more viral genes(Brooke et al. 2013). When carrying out 
the primary infection at a low MOI, we generate populations of infected cells that are 
either positive or negative for expression of a given viral gene. We can then assess the 
effects of specific viral proteins on superinfection susceptibility by comparing 
superinfection frequencies between infected cells that do or do not express the protein in 




We performed the same superinfection experiment as described above in MDCK cells; 
however, we used slightly different viruses to ensure that the NA specificity of the 
primary virus was well matched to the HA specificity of the secondary virus. The 
primary virus used here encoded the HA gene from A/Udorn/72 and the NA gene from 
PR8 (rH3N1), while the secondary virus encoded the HA gene from PR8 and the NA 
gene from A/Udorn/72 (rH1N2). The remaining 6 segments for both viruses came from 
PR8. 
 
At 19 hpi, we harvested and stained with MAbs against H1, N1, and H3. To compare 
rH3N1 infected cells that did or did not express NA, we individually gated cells into 
H3+ N1+ and H3+ N1− subpopulations (Fig. 2.2A). Comparison of H1+ frequencies 
between H3+ N1+ and H3+ N1− cells revealed that NA expression in infected cells was 
clearly associated with decreased susceptibility to superinfection (Fig. 2.2B). This finding 
was consistent with the previously reported role for NA in IAV superinfection 
exclusion(I.-C. Huang et al. 2008). Importantly, while SIE was more pronounced in the 
H3+ N1+ cells, we also observed a significant decrease in superinfection susceptibility 
within the H3+ N1− cell population by 6 hpi, suggesting that viral factors other than NA 
also act to restrict superinfection. 
 
To directly test whether NA enzymatic activity was required for the increased potency of 
SIE that we observed in NA+ cells, we asked whether treatment with the NA inhibitor 
(NAI) zanamivir could diminish this effect. We observed that the addition of zanamivir at 
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1 uM (a concentration that completely blocked rH3N1 NA enzymatic activity) did not 
decrease the strength of SIE in NA+ cells (Fig. 2.2B,2.8). We also examined the effects of 
two substitutions (NP:F346S and NA:K239R) that decrease cellular NA expression 
relative to wild-type PR8 on superinfection efficiency(Brooke et al. 2014; Hensley et al. 
2011) (Fig. 2.9A). In accordance with our zanamivir results, these mutants did not exhibit 
higher superinfection frequencies than wild-type PR8 (Fig. 2.9B). Taken together, these 
results reveal that superinfection is more effectively inhibited by virions that express NA 
than by those that do not, but that NA enzymatic activity is dispensable for this effect. 
 
Superinfection susceptibility is determined by the number of viral genes expressed 
in cell 
On the basis of our observation that superinfection was also inhibited within N1− cells 
(Fig. 2.2B), we hypothesized that expression of other viral gene products might also 
inhibit superinfection. We examined the effects of HA and NS1 expression on 
superinfection susceptibility, using rPR8-specific MAbs. Surprisingly, we found that both 
HA expression and NS1 expression within rPR8-infected cells were associated with 
significant decreases in superinfection by rH3N2 and that the results were comparable to 
the effect associated with NA expression (Fig. 2.3A,B). To further dissect how viral gene 
expression patterns influence SIE, we individually gated all seven possible combinations 
of HA, NA, and NS1 expression by rPR8 (HA+ NA+ NS1+, HA+ NA+, HA+ NS1+, 
NA+ NS1+, HA+, NA+, NS1+) and directly compared their rH3N2 infection frequencies 
(the gating scheme is shown in Fig. 2.10A). We observed that the fraction of cells 
superinfected with rH3N2 was inversely correlated with the number of rPR8 genes 
35 
 
expressed (among the three we examined), regardless of their specific identities 
(Fig. 2.3C,D). Thus, susceptibility to IAV superinfection is determined by the number of 
viral genes expressed in the host cell by the initially infecting virion. 
 
Superinfection is more prevalent in IAV populations with more SIPs 
If the number of viral genes expressed in a cell determines superinfection susceptibility, 
then decreasing the average number of functional viral genes successfully delivered by 
individual virions should increase the overall incidence of superinfection. We tested this 
by artificially decreasing the functional gene segment content of rPR8 through exposure 
to UV irradiation(Fonville et al. 2015). Exposure to low-dose UV irradiation generates 
SIPs that carry gene-lethal UV-induced lesions at frequencies proportional to genome 
segment length. On the basis of our previous findings, we hypothesized that 
superinfection frequencies would increase with longer exposure of rPR8 to UV. 
 
We used UV (302-nm wavelength) to irradiate rPR8 for either 30 s or 60 s and confirmed 
that the TCID50 concentration was reduced and the SIP concentration was increased as a 
function of treatment duration (Fig. 2.4A-C). We then performed superinfection assays as 
described above, comparing rH3N2 superinfection frequencies following infection by 
untreated or UV-irradiated rPR8 in MDCK cells. To fairly compare superinfection 
frequencies between viral populations with differing particle-to-infectivity ratios, we 
normalized our rPR8 infections based on equivalent numbers of particles capable of 




We first examined the effect of UV treatment on superinfection when rPR8 and rH3N2 
were added to cells simultaneously (at 0hr). This was a critical control because UV 
treatment can increase the measured incidence of coinfection, independently of SIE 
effects, purely by creating a larger pool of SIPs that show up in our assays only when 
complemented by secondary infection(Fonville et al. 2015). Consistent with this, we 
observed a small increase in coinfection frequency with UV treatment when the two 
viruses were added simultaneously (Fig. 2.4D,E). When rH3N2 was added 6 h after 
rPR8, however, we observed a much more pronounced increase in superinfection 
frequency with UV treatment, consistent with our hypothesis that superinfection can be 
regulated by the proportion of SIPs present within the viral population (Fig. 2.4D-F). 
 
SIE is mediated by active IAV replication complexes and is independent of the gene 
coding sequence 
Our data reveal that IAV superinfection potential is determined by the number of viral 
genes expressed within a cell, independent of their specific identity. This suggests that 
the viral gene products themselves are dispensable for SIE. We thus hypothesized that 
active replication and/or transcription of viral RNAs by the viral replicase complex might 
be responsible for decreasing cellular susceptibility to subsequent infection. To test this, 
we cotransfected 293T cells with pDZ vectors encoding the individual viral replicase 
proteins (PB2, PB1, PA, and NP) together with a pHH21 vector encoding either the HA 
vRNA gene segment (HAvRNA) or a vRNA-derived reporter gene segment in which the 
enhanced green fluorescent protein (eGFP) open reading frame (ORF) is flanked by the 5′ 
and 3′ untranslated-region (UTR) sequences from the NA segment (eGFPvRNA). These 
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UTR sequences are required for replication and transcription of the reporter RNA by the 
viral replicase. At 24 h post-transfection, we infected cells with rH3N2 at a MOI of 0.2 
TCID50/cell and measured infectivity at 8 hpi using an M2-specific MAb. 
 
Infection frequencies were decreased ∼50% in cells expressing the replicase components 
plus the eGFPvRNA construct compared with control cells transfected with the replicase-
expressing constructs plus an empty pHH21 vector (Fig. 2.5A). In analyses of differences 
in the levels of rH3N2 infectivity between cotransfected cells (eGFP+, HA+) and 
uncotransfected cells (eGFP−, HA−) within the same culture wells, the inhibitory effects 
mediated by eGFPvRNA or HAvRNA expression were found to be comparable 
(Fig. 2.5B,2.11). Importantly, this effect was not seen when we left out the plasmid 
encoding PA (RNPPA−) or used an eGFP reporter RNA that lacked the viral UTR 
sequences (eGFPORF) (Fig. 2.5A). Taken together, these data indicate that inhibition of 
infection requires both an intact replicase complex and an RNA template containing the 
viral UTR sequences but not the viral coding sequence. 
 
Our data demonstrate that IAV SIE is mediated by the specific activity of viral replication 
complexes. One potential explanation is that large amounts of recently synthesized 
negative sense vRNA within the cell might outcompete incoming genome segments for 
replication and expression. To test this, we transfected 293T cells with a pHH21 vector 
that overexpresses the eGFPvRNA segment and measured susceptibility to rH3N2 infection 
24 h later using an NP-specific MAb. Compared to the empty vector control, we observed 
no effect of eGFPvRNA vRNA overexpression on cellular susceptibility to infection 
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(Fig. 2.5C). Similarly, we observed no effect when we overexpressed the cRNA and 
vRNA forms of the HA gene segment, either individually or together (Fig. 2.5C). It must 
be noted that bulk levels of viral RNA were roughly 5-fold lower in these cells than in 
cells that express the viral replicase, so we cannot rule out a role for the intracellular 
abundance of viral RNA as a determinant of susceptibility to subsequent infection 
(Fig. 2.12). 
 
Another potential explanation is that viral mRNA or protein overexpression might inhibit 
subsequent infection. To test this, we transfected 293T cells with pCI vectors that 
overexpress mRNA and protein of eGFP and HA and measured susceptibility to rH3N2 
infection 24 h post-transfection using the M2-specific MAb. Compared to the empty 
vector control, mRNA/protein overexpression of eGFP or HA had no effect on infection 
susceptibility (Fig. 2.5D,2.13). Collectively, these data demonstrate that IAV 
superinfection exclusion is triggered by the activity of viral replication complexes. 
 
2.3 Discussion 
Superinfection plays an enormous role in influencing the outcome of IAV infection, both 
by promoting reassortment and by facilitating the multiplicity reactivation of SIPs and 
defective interfering particles(Brooke 2017). Despite this importance, the specific factors 
that govern the occurrence of superinfection have remained obscure. Here, we reveal that 
IAV superinfection susceptibility is regulated by the number of viral genes successfully 
expressed by a virion. We further demonstrate that the presence of SIPs within viral 
populations significantly increases the frequency of superinfection. This represents a 
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completely novel mechanism of viral superinfection exclusion and identifies a clear 
functional consequence of the enormous genomic heterogeneity within IAV populations. 
 
The only other published study that examined IAV SIE in detail concluded that NA 
expression mediates SIE by depleting the pool of available sialic acid receptors on the 
cell surface(I.-C. Huang et al. 2008). In this study, we directly quantified the contribution 
of NA expression to SIE during IAV infection and found that the SIE effect of NA 
expression is actually comparable to that of other viral genes. We also show that 
treatment with NAIs has no appreciable effect on superinfection susceptibility. The 
conclusions of the study by Huang et al. were based primarily on two observations: (i) 
overexpression of NA within cells rendered them refractory to infection by an HA-
pseudotyped virus, and (ii) IAV superinfection occurred only when cells were treated 
with NAIs. While we cannot conclusively explain the discrepancies between the two 
studies, we can offer a couple of plausible explanations. First, the cellular overexpression 
studies in Huang et al. likely involved levels of cellular NA expression that are far 
beyond those seen during IAV infection. Second, the observation that NAI treatment 
dramatically increases superinfection frequencies may be explained by the effects of cell 
death. In their experiments, Huang et al. infected cells at a relatively high MOI, did not 
block secondary spread of the virus within cultures, and assessed superinfection 
frequency at 20 hpi or later. Under those conditions, many of the initially infected cells 
may have been dead or dying and thus lost from the analysis. That may be especially true 
of superinfected cells, which tend to be infected at a higher than the average effective 
MOI. Even under low-MOI conditions, we had to limit the time frame of our experiments 
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and block secondary spread of virus to prevent cell death from skewing our results. NAI 
treatment may act to help preserve coinfected cells so that they are detected at the 
endpoint of the experiment, thus increasing the measured superinfection rate. 
 
Our results reveal that SIE is triggered in a dose-dependent fashion by the number of 
functional viral gene segments delivered by the initially infecting virion. The surprising 
irrelevance of the specific IAV gene segments involved is explained by our finding that 
the viral coding sequence of a gene segment can be replaced with that of eGFP without 
any loss of inhibitory effect. This suggests a direct role for viral replicase activity itself in 
triggering SIE rather than any effect of the viral gene segments themselves. We 
hypothesize that the overall levels of replicase activity in the cell, particularly during the 
early stages of infection, are determined by the number of functional RNPs delivered to 
the cell. Thus, cells infected by SIPs that deliver fewer functional RNPs exhibit lower 
overall levels of replicase activity, resulting in less-potent SIE. 
 
The specific mechanism by which the activity of viral replicase complexes may inhibit 
subsequent infection remains unclear; however, one potential explanation is that the 
activity of viral replication complexes triggers a cell-intrinsic antiviral response. As each 
incoming gene segment brings its own replicase complex, this could potentially explain 
the gene dose-dependent suppression of superinfection that we observed. While our 
experiments in Vero cells demonstrated that the secretion of type I IFN is not required for 
SIE, they do not preclude the involvement of type I IFN-independent mechanisms. These 
could include either the type III IFN-mediated induction of antiviral effectors or the 
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engagement of completely IFN-independent antiviral mechanisms(Dixit et al. 2010; 
Wack, Terczyńska-Dyla, and Hartmann 2015; Odendall and Kagan 2015). Future studies 
will be aimed at delineating the role of the host in the regulation of IAV superinfection. 
 
Our results demonstrate that SIPs can directly influence the prevalence of superinfection 
and thus, potentially, the frequency of reassortment. Fonville et al. used a UV irradiation-
based method similar to that shown here to demonstrate that increasing the frequency of 
SIPs within a viral population increases the overall reassortment rate(Fonville et al. 
2015). The explanation given for this effect was that increasing the abundance of SIPs 
increases the proportion of the viral population that depends upon coinfection to 
replicate. As a result, within a certain MOI range, a greater share of productively infected 
cells is coinfected and subject to reassortment. In our study, we confirmed this effect by 
observing a slight increase in coinfection frequency with increasing UV dose when rPR8 
and rH3N2 were added simultaneously (Fig. 2.4E). When we controlled for this, 
however, we still observed a significant increase in superinfection frequency as we 
increased the proportion of SIPs through UV treatment (Fig. 2.4D-F). Thus, the 
relationship between SIPs and SIE that we describe here is completely independent of the 
increased multiplicity reactivation observed by Fonville et al. and likely represents the 
effects of decreasing the strength of SIE. Between these two studies, it is clear that SIPs 





IAV strains can differ significantly with respect to the relative production and gene 
expression patterns of SIPs(Brooke et al. 2013; 2014). This raises the possibility that 
strains with distinct SIP production phenotypes may differ in their reassortment potential, 
given the influence of SIPs on coinfection and reassortment frequencies. If this is the 
case, it would suggest a significant role for production of SIPs in governing the 
evolutionary potential of IAV populations. 
 
The relationship between viral gene expression patterns and superinfection exclusion that 
we report here demonstrates that viral genomic heterogeneity has distinct functional 
consequences during infection. A crucial implication is that all infected cells cannot be 
thought of as equal but may in fact exhibit distinct phenotypes based on the number and 
identity of viral genome segments that they harbor(Diefenbacher, Sun, and Brooke 2018). 
The relationship between viral genomic heterogeneity and the phenotypic diversity of 
infected cells likely extends to cellular features beyond superinfection susceptibility. 
 
It remains to be seen whether the relationship between viral gene dose and superinfection 
susceptibility that we describe here exists for other segmented viruses besides IAV. 
Beyond the segmented viruses, it has become increasingly clear that collective 
interactions mediated by cellular coinfection significantly influence the replicative and 
evolutionary dynamics of non-segmented viruses as well(Sanjuán 2017). More work is 
needed to better understand the factors that govern coinfection for different virus 




In summary, our work reveals a unique mechanism of IAV superinfection regulation that 
is governed by viral genomic heterogeneity. Critically, we show that the abundance of 
SIPs within a viral population directly influences the prevalence of superinfection; 
suggesting that IAV strains may differ in their superinfection potential and thus in their 
potential for reassortment. This finding has significant consequences for understanding 
how SIP production can influence the evolutionary potential of IAV populations. More 
broadly, we demonstrate how genomic diversity within viral populations can have clear 
functional consequences during infection. 
 
2.4 Materials and methods 
Plasmids 
The A/Puerto Rico/8/34 and A/Udorn/72 reverse genetics plasmids were generous gifts 
from Adolfo Garcia-Sastre and Kanta Subbarao, respectively. The pCI vector was 
graciously provided by Joanna Shisler. pHH21::eGFPvRNA (eGFP ORF flanked by the 
NA UTRs) was kindly gifted by Andrew Mehle. Generation of pHH21::HAvRNA has been 
previously described. The following primer pairs were used to generate the indicated 
constructs: for pHH21::eGFPORF (BsmBI), 5′-
CGTCTCCTATTTTACTTGTACAGCTCG and 3′ 
CGTCTCCGGGATGGTGAGCAAGGGC; for pHH21::HAcRNA (BsmBI), 
5’CGTCTCATATTAGCAAAAGCAGG and 3′ 
CGTCTCAGGGAGTAGAAACAAGGG; for pCI::eGFPORF (EcoRI/SalI), 5′-
AGAATTCATGGTGAGCAAGG and 3’AGTCGACTTACTTGTACAGC; for 
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Madin-Darby canine kidney (MDCK) and human embryonic kidney HEK293T (293T) 
cells were maintained in Gibco’s minimal essential medium (MEM) with GlutaMax (Life 
Technologies). Vero cells were maintained in Dulbecco’s modified Eagle medium (Life 
Technologies). Human lung epithelial A549 cells were maintained in Gibco’s F-12 
medium (Life Technologies). MDCK, Vero, and A549 cells were obtained from Jonathan 
Yewdell; 293T cells were obtained from Joanna Shisler. All media were supplemented 
with 8.3% fetal bovine serum (Seradigm). Cells were grown at 37°C and 5% CO2. 
 
Viruses 
Recombinant A/Puerto Rico/8/1934 (rPR8) and rH3N2 viruses were generated using 8-
plasmid rescue systems. The rH3N2 virus is a reassortant with the HA and NA segments 
from A/Udorn/72 (H3N2), the NS segment from A/California/04/09 (H1N1), and the 
other 5 segments from PR8. The rPR8 clones differ from the published sequence 
(GenBank accession no. AF389115 to AF389122) at two positions: PB1 A549C (K175N) 
and HA A651C (I207L) (numbering from initiating Met). Molecular clone-derived 
mutants (rPR8 NP:F346S and rPR8 NA:K239R) were generated using standard site-
directed PCR mutagenesis. rH3N1 and rH1N2 viruses used in superinfection studies were 
similarly generated through reverse genetics, using the HA and NA segments from 
A/Udorn/72 (H3N2) respectively and the remaining segments from PR8. All viruses were 
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rescued by transfecting subconfluent 293T cells with 500 ng of each of the appropriate 
reverse genetics plasmids using JetPRIME (Polyplus) according to the manufacturer’s 
instructions. Plaque isolates derived from rescue supernatants were amplified into seed 
stocks in MDCK cells. Working stocks were generated by infecting MDCK cells at a 
MOI of 0.0001 TCID50/cell with seed stock and collecting and clarifying supernatants at 
48 hpi. All viral growth was carried out in MEM with 1 ug/ml trypsin treated with L-
(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK-treated trypsin; Worthington), 
1 mM HEPES, and 100 ug/ml gentamicin. The titers of the virus stocks were determined 
via standard 50% tissue culture infectious dose (TCID50) assay. 
 
Superinfection assay 
For the 6-h sequential-infection group, confluent mammalian cells (MDCK, Vero, A549, 
or 293T) in six-well plates were infected with rPR8 at a MOI of <0.3 TCID50/cell for 1 h. 
At 1 h post-adsorption, monolayers were washed with phosphate-buffered saline (PBS) 
and incubated in serum-containing medium. At 3 hpi, neutralizing anti-PR8-HA mouse 
MAb H17-L2 (5 ug/ml) was added to cultures to prevent spread of rPR8. At 6 hpi, 
monolayers were superinfected with rH3N2 at an MOI of <0.3 TCID50/cell in the 
presence of H17-L2 (which does not interfere with rH3N2 infection) (Fig. 2.7). At 1 h 
post-adsorption, monolayers were washed with PBS and incubated in serum-containing 
medium with H17-L2. At 9 hpi of rPR8 (3 hpi of rH3N2), the medium was changed to 
MEM with 50 mM HEPES and 20 mM NH4Cl to block spread of both viruses. At 19 hpi 




For the 0-h simultaneous infection group, cells were infected with a mixture of rPR8 and 
rH3N2 at the same MOIs as in 6-h superinfection group. The NH4Cl medium was added 
to block viral spread at 3 hpi, and cells were harvested at 19 hpi. 
 
All cells were simultaneously fixed and permeabilized using foxP3 fix/perm buffer 
(eBioscience). Fixed cells were stained with Alexa Fluor 488-conjugated mouse anti-H1 
MAb H36-26 (which does not compete with H17-L2), Pacific Orange-conjugated mouse 
anti-N1 MAb NA2-1C1, Pacific Blue-conjugated mouse anti-NS1 MAb NS1-1A7, and 
Alexa Fluor 647-conjugated mouse anti-H3 MAb H14-A2 (all MAbs were gifts from Jon 
Yewdell). After staining was performed, cells were washed, run on a BD LSR II flow 
cytometer, and analyzed using FlowJo version 10.1 (Tree Star, Inc.). Importantly, the 
expression patterns of H1, H3, N1, and NS1 allowed clear gating of positive and negative 
populations. 
 
NA activity inhibition assay 
The NA inhibitor zanamivir (Sigma) (10 ug/ml) was 2-fold serially diluted in assay buffer 
[33 mM 2-(N-morpholino) ethane-sulfonic acid (pH 6.5), 4 mM CaCl2] and mixed with 
2.2 × 106 TCID50 of rH3N1 virus in a final volume of 50 ul. On a 96-well half-well flat-
bottom plate (Corning 3686), 25 ul of the virus-NAI mixture was mixed with 20 ul of the 
fluorogenic substrate MUNANA [2′-(4-methylumbelliferyl)-α-D-N-acetylneuraminic 
acid] (Sigma) diluted in assay buffer [33 mM 2-(N-morpholino)ethane-sulfonic acid (pH 
6.5), 4 mM CaCl2]. In the mixture, the final concentration was 200 uM for the substrate 
and ranged from 0.0625 uM to 1 uM for zanamivir. No-drug controls and no-virus 
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controls were also included. Immediately after the addition of the substrate, fluorescence 
was measured every 5 min over a 30-min period on a SpectraMax M2 microplate reader 
(Molecular Devices). Michaelis-Menten kinetics were determined for each dilution of 
zanamivir to estimate the maximum rate of metabolism (Vmax) values. 
 
Quantification of NA expression 
H1+ N1+ MDCK cells infected with rPR8WT, rPR8 NP:F346S, or rPR8 NA:K239R in 
the superinfection assay (6-h group) were gated, and histograms for NA expression were 
plotted. The geometric mean fluorescence intensities (GMFI) for NA were determined 
using FlowJo version 10.1 (Tree Star, Inc.). 
 
UV treatment and analysis 
rPR8 stocks were placed in six-well plates (500 ug/well) on ice. Plates were placed 5 cm 
underneath a 302-nm-wavelength UVP-57 handheld UV lamp (UVP) and irradiated for 
30 s or 60 s. TCID50 titers and single virion expression patterns of untreated and UV-
treated virus were determined on MDCK cells, and the superinfection assays described 
above were performed using these viruses and rH3N2. 
 
Transfection assay 
293T cells (80% confluent) in six-well plates were transfected with the following 
plasmids using jetPRIME (Polyplus): RNP (500 ng each of pDZ::PB2, pDZ::PB1, 
pDZ::PA, and pDZ::NP) plus 1 ug of pHH21 vector; RNP plus 1 ug of 
pHH21::eGFPvRNA (eGFPORF flanked with NA UTRs); RNP plus 1 ug of 
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pHH21::eGFPORF; RNP plus 1 ug of pHH21::HAvRNA; RNPPA− (500 ng each of 
pDZ::PB2, pDZ::PB1, pDZ, and pDZ::NP) plus 1 ug of pHH21::eGFPvRNA; RNPPA− plus 
1 ug of pHH21::HAvRNA; 6 ug of pHH21 vector; 3 ug of pHH21 vector plus 3 ug of 
pHH21::eGFPvRNA; 3 ug of pHH21 vector plus 3 ug of pHH21::HAvRNA; 3 ug of pHH21 
vector plus 3 ug of pHH21::HAcRNA; 3 ug of pHH21::HAvRNA plus 3 ug of 
pHH21::HAcRNA; 3 ug of the pCI vector; 3 ug of pCI::eGFPORF; 3 ug of pCI::HAORF. All 
plasmid-encoded viral sequences were derived from PR8. At 24 h post-transfection, 
monolayers were infected with rH3N2 at a MOI of 0.2 TCID50/cell. At 8 hpi, cells 
transfected by RNP+ pHH21, and pCI plasmids were harvested and stained with Alexa 
Fluor 488-conjugated mouse anti-H1 MAb H36-26 and Alexa Fluor 647-conjugated 
mouse anti-M2 MAb O19. Cells transfected with pHH21 plasmids were permeabilized, 
fixed, and stained with Alexa Fluor 647-conjugated mouse anti-NP MAb HB-65. After 
staining, cells were washed and run on a BD LSR II flow cytometer, and virus infection 
frequencies, as measured by fractions of M2+ or NP+ cells, were quantified using FlowJo 
version 10.1 (Tree Star, Inc.). 
 
Intracellular viral RNA quantification 
Subconfluent 293T cells in six-well plates were infected with rPR8 at an MOI of 0.5 HA-
expressing units (HAEU)/cell or were transfected with the following plasmids using 
jetPRIME (Polyplus): 3 ug of pHH21 vector plus 3 ug of pHH21::HAvRNA; RNP (500 ng 
each of pDZ::PB2, pDZ::PB1, pDZ::PA, and pDZ::NP) plus 1 ug of pHH21::HAvRNA. At 
6 hpi and 24 h post-transfection, cells were harvested, and RNA was extracted using a 
RNeasy minikit (Qiagen). cDNA of cellular mRNA and cDNA of HA vRNA were 
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reverse transcribed with oligo(dT)20 or MBTuni (5′-
ACGCGTGATCAGCAAAAGCAGG) reverse transcriptase (RT) primers using 
Superscript III (Invitrogen). Quantitative real-time PCR on cDNA was carried out using 
Power SYBR green PCR Master Mix (Thermo Fisher) on a QuantStudio 3 thermal cycler 
(Thermo Fisher). The strand-specific primers for quantitative real-time PCR of HA 
vRNA and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA were as 
follows: for GAPDH317F, CTGGGGCTCACTTGAAAGG; for GAPDH388R, 
CAAACATGGGGGCATCAG); for HA, F (forward) 
(AAGGCAAACCTACTGGTCCTGTT) and R (reverse) 
(AATTGTTCGCATGGTAGCCTATAC). Delta threshold cycle (ΔCT) values for viral 
RNA were calculated by subtracting GAPDH CT values from HA CT values. 
 
Statistical analysis 
Unpaired, two-sided Student’s t tests were applied to the data shown 
in Fig. 1B, 2B, 3A, 3B, and 4F. An unpaired, two-sided Welch’s t test was applied to the 















Figure 2.1 A 6-h delay between primary infection and superinfection allows robust 
superinfection exclusion. The indicated mammalian cell lines were infected with rPR8 
virus and were simultaneously (0hr) or sequentially (6hr) infected with rH3N2 virus; all 
infections were performed at MOI = <0.3 TCID50/cell. (A) Representative fluorescence-
activated cell sorter (FACS) plots showing expression of H1 versus H3 within MDCK 
cells. (B) H3+ frequencies within H1+ cells following simultaneous or sequential 
infection, in the indicated cell lines. The values for both the 0-h and 6-h groups are shown 
as percentages of the mean values of the 0-h control group to clearly illustrate the 
percentages of reduction in cellular susceptibility in the 6-h group. Data are presented as 

















Figure 2.2 Superinfection exclusion is more potent in infected cells that express NA but 
is independent of NA enzymatic activity. MDCK cells were infected with rH3N1 virus 
and were simultaneously (0hr) or sequentially (6hr) infected with rH1N2 virus; all 
infections were performed at MOI = <0.3 TCID50/cell. During the 5-h gap and 1-h 
adsorption of the secondary infection (rH1N2), cells were incubated in either medium 
alone or media with 1 µM zanamivir (NAI). (A) Representative FACS plots comparing 
H1+ frequencies between H3+ N1− and H3+ N1+ cells. (B) H1+ frequencies within 
H3+ N1− and H3+ N1+ cells following simultaneous (0hr) or sequential (6hr) infection. 
Values of both the 0-h and 6-h groups (with or without the presence of NAI) are 
normalized to the means of 0-h controls, and data are presented as mean values (n = 3 cell 










Figure 2.3 Superinfection is more frequent in cells that express fewer viral genes. 
MDCK cells were infected with rPR8 and were simultaneously (0hr) or sequentially (6hr) 
infected with rH3N2; all infections were performed at MOI = <0.3 TCID50/cell. (A and 
B) Representative FACS plots comparing H3+ frequencies between (A) N1+ H1− and 
N1+ H1+ cells and (B) H1+ NS− and H1+ NS+ cells. (C) Superinfection assay performed as 
described for panels A and B; however, cells are gated into all 8 possible combinations of 
HA, NA, and NS1 expression by rPR8, and H3+ percentages are compared between these 
subpopulations. Data represent the values of 6hr groups normalized to the means of 0hr 
controls. Each data point represents the H3+ frequency for the indicated cell population 
within a single cell culture well, shown as a percentage of the mean H3+ frequency of the 
same cell subpopulation in the 0hr controls. (D) Data from panel C grouped by total 
numbers of the three examined viral gene products (HA, NA, and NS1) expressed by 
rPR8 rather than by their specific identities. *, P < 0.05; **, P < 0.01; ***, P < 0.001; 





Figure 2.4 Superinfection is more common in viral populations that contain more SIPs. 
rPR8 was irradiated by the use of a 302-nm-wavelength UV lamp for 30 s or 60 s. (A) 
TCID50 titers of untreated rPR8 (0 s) or rPR8 subjected to UV treatment for 30 s and 60 s. 
Pooled data from two independent experiments are shown. (B) Representative FACS 
plots showing HA versus NA expression patterns of untreated rPR8 (0 s) and rPR8 
subjected to UV treatment for 60 s. (C) Quantification of H1− and N1− SIPs in untreated 
rPR8 (0 s) or rPR8 subjected to UV treatment for 30 s and 60 s. (D) MDCK cells were 
infected with untreated rPR8 (0 s) or with rPR8 subjected to UV treatment for 30 s and 
60 s at an MOI of 0.04 NAEU/cell and were simultaneously (0hr) or sequentially (6hr) 
infected with rH3N2 at MOI < 0.3 TCID50/cell. Representative FACS plots showing 
expression of N1 versus H3 in cells infected with untreated rPR8 (0 s) or with rPR8 
subjected to UV treatment for 60 s. (E) rH3N2 infection percentages within N1+ cells 
infected with untreated rPR8 (0 s) or with rPR8 subjected to UV treatment for 30 s and 
60 s. (F) Values corresponding to the 6hr groups in panel E normalized to means of 0hr 
controls. For panels E and F, data are presented as mean values (n = 3 cell culture wells) 








Figure 2.5 Viral replicase activity inhibits subsequent infection. (A) Subconfluent 293T 
cell monolayers were transfected with: vectors encoding the complete set of viral 
replicase proteins (PB2, PB1, PA, and NP) together with empty pHH21 vector with the 
PolI promoter (RNP+pHH21), pHH21 encoding a reporter viral RNA with eGFP ORF 
plus 5′ and 3′ viral UTR sequences (RNP + eGFPvRNA), pHH21 encoding eGFP ORF 
without the viral UTRs (RNP + eGFPORF), and vectors encoding an incomplete set of 
viral replicase proteins (PB2, PB1, and NP only; no PA) along with pHH21 encoding the 
reporter viral RNA (RNPPA- + eGFPvRNA). At 24 h post-transfection, cells were infected 
with rH3N2 at MOI = 0.2 TCID50/cell. At 8 hpi, cells were harvested and assessed for 
rH3N2 infection via flow cytometry. For each group, rH3N2 infectivities are presented as 
the percentages of the mean rH3N2 infectivity in the RNP + pHH21 vector control group. 
(B) Experiment performed as described for panel A with cotransfection of plasmids 
encoding the complete set of viral replicase proteins plus either pHH21::eGFPvRNA or 
pHH21::HAvRNA. Data representing rH3N2 infectivity in cotransfected cells (eGFP
+ or 
HA+) are normalized to uncotransfected cells (eGFP− or HA−) in the same samples. (C) 
Experiment performed as described for panel A with transfection of empty vector 
(pHH21) or vectors encoding indicated RNA products. rH3N2 infectivities are presented 
as the percentages of the mean rH3N2 infectivity in the vector control group. (D) 
Experiment performed as described for panel A with transfection of empty vector (pCI) 
or vectors encoding eGFP or HA protein. Data representing rH3N2 infectivity in 
transfected cells (eGFP+ or HA+) are normalized to untransfected cells (eGFP− or HA−) in 






Figure 2.6 Levels of expression of HA, NA, and NS1 by rPR8 and rH3N2 can be 
differentiated using specific MAbs. MDCK cells were infected with rPR8 or rH3N2 at a 
MOI of <0.3 TCID50/cell. At 19 hpi, cells were harvested, fixed, permeabilized, stained 
against H1 (H36-26), N1 (NA2-1C1), NS1 (1A7), and H3 (H14-A2), and run on an LSR 
II flow cytometer. The results of analyses of expression of H1 versus N1 and of NS1 










Figure 2.7 Superinfection is inhibited in multiple cell lines. Levels of H1 expression 
versus H3 expression in Vero cells, A549 cells, and 293T cells observed in the 










Figure 2.8 Viral NA activity is blocked by 1 µM zanamivir. (A) NA activity of rH3N1 
virus used in the experiment described in the Fig 2 legend. Data represent results of 
determinations of relative fluorescence units (RFU) against time under conditions of 
increasing concentrations of zanamivir. (B) Vmax of reactions performed as described for 












Figure 2.9 Superinfection exclusion is independent of NA expression level. MDCK cells 
were infected with rPR8WT, rPR8NP:F346S, or rPR8NA:K239R and were simultaneously (0hr) 
or sequentially (6hr) infected with rH3N2; all infections were performed at MOI = <0.3 
TCID50/cell. (A) Comparison of NA expression levels within H1
+ N1+ cells between 
rPR8WT, rPR8NP:F346S, and PR8NA:K239R at 19 hpi. (B) Comparison of H3
+ frequencies 
within H1+ N1− and H1+ N1+ cells between the three indicated viruses. Values from h 6 
groups are normalized to means of h 0 controls. Data are presented as mean values (n = 3 



























Figure 2.10 Gating scheme used for measuring the effect of the number of viral genes 
expressed on superinfection frequencies. (A) Cells from the experiment described in 
the Fig. 3 legend were assessed for expression of HA, NA, and NS1 sequentially. The 
fractions of H3+ cells (indicative of superinfection rates) were quantified and compared 
between the cell populations with the indicated viral gene expression patterns. (B) 
Representative FACS plots showing the gates used to assess HA, NA, and NS1 











Figure 2.11 Cells cotransfected with plasmids encoding viral replicase and viral RNA are 
less susceptible to subsequent infection. Cells from the experiments described in 
the Fig. 5A,B legends were assessed for expression of M2 (indicative of rH3N2 
infection) versus eGFP and HA (indicative of cotransfection) as shown in representative 
















Figure 2.12 Comparison of intracellular viral RNA levels measured under different 
experimental conditions. (A) Relative amounts of HA vRNA in 293T cells transfected 
with pHH21::HAvRNA or cotransfected with plasmid-derived viral replicase complex plus 
pHH21::HAvRNA for 24 h or infected with rPR8 for 6 h at MOI = 0.5 HAEU/cell were 
determined by strand-specific quantitative real-time PCR, including the no-reverse-
transcription control. Data shown are delta threshold cycle (ΔCT) values for HA vRNA 
versus GAPDH mRNA. (B) Relative amounts of HA viral RNA shown as fold 
differences compared with HAvRNA. Data are presented as mean values (n = 2 cell culture 






Figure 2.13 Overexpression of viral mRNA and protein in cells does not inhibit 
subsequent infection. (A) Cells from the experiment described in the Fig. 5D legend were 
assessed for expression of M2 (indicative of rH3N2 infection) versus eGFP and HA 
(indicative of transfection) in representative FACS plots. (B) rH3N2 infectivity data from 
panel A are shown as percentages of pCI vector. Data are presented as mean values (n = 2 










Superinfection exclusion (SIE) occurs when the host cell infected by a virus become 
refractory to the subsequent infection of another virus. To date, SIE has been observed in 
multiple RNA viruses, including IAV (IAV)(I.-C. Huang et al. 2008; Nethe, Berkhout, 
and van der Kuyl 2005; Schaller et al. 2007; Zou et al. 2009; X.-F. Zhang et al. 2017; 
Laliberte and Moss 2014). It is clear that the extent of SIE regulates viral co-infection 
rate, the fraction of cells infected by multiple virus particles(Marshall et al. 2013). Since 
both multiplicity reactivation (complementation of semi-infectious particles) and 
reassortment (exchange of gene segments between different IAVs) require co-infection to 
occur, SIE is a major determinant of IAV replicative and evolutionary potentials(Brooke 
2017). Despite the huge importance, the mechanisms that mediate SIE in IAV remain 
poorly understood. Here, we aim to define novel viral and host determinants of SIE to 
better understand the mechanisms.   
 
3.2 Results 
SIE is enhanced by cellular co-infection  
We previously showed that under low MOI condition where co-infection is rare, 
increasing the number of functional gene segments delivered to a given cell resulted in 
more potent SIE, limiting the potential for cellular co-infection in a cell-type independent 
manner. Therefore, we hypothesized that increases in cellular MOI of the primary 
infection would shorten the time window during which superinfection is possible, 
enhancing SIE. To more quantitatively describe the relationship between MOI and SIE, 
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we collaborated with Dr. Katia Koelle who developed different mathematical models and 
tested which model best explains our experimental data. 
 
To define how cellular MOI affects subsequent superinfection potential, we measured the 
extent of SIE across a range of bulk MOIs in MDCK cells. We generated 2 antigenically 
distinct reassortant viruses (rH3N1 and rH1N2) that could be differentiated using specific 
monoclonal antibodies. We infected MDCK cells with rH3N1 at a range of intended 
MOIs resulting in groups with average bulk MOIs of 0.25, 1.13, 3.00, 15.43, and 53.72 
TCID50/cell (based on subtracting post-adsorption inoculum GE titers from pre-
adsorption inoculum titers as detailed in methods). At 6 hpi, we superinfected with a 
constant bulk input MOI of 0.5 TCID50/cell of rH1N2. To measure the baseline co-
infection rates in the absence of SIE effects, we included co-infection controls for each 
input MOI where we simultaneously co-infected with rH3N1 and rH1N2 viruses. At 19 
hpi, we examined the infection status of cells by flow cytometry, using H3 and H1 
expression as markers of rH3N1 infection and rH1N2 infection, respectively. 
As expected, during simultaneous co-infection (where no SIE occurs), we observed that 
the fraction of co-infected cells (H3+H1+) increased with the input MOI of rH3N1 virus 
and plateaued when almost all rH1N2-infected cells (H1+) were co-infected with rH3N1 
(Fig 3.1A). These simultaneous co-infection data were used to develop and parameterize 
an appropriate “null” model of co-infection in the absence of SIE. To capture the 
possibility of overdispersion of viral particles, the null model assumed that cells could 




In contrast to what was observed under simultaneous co-infection conditions, under 
superinfection conditions we observed that the fractions of both double-infected 
(H3+H1+) cells and rH1N2-infected (H1+) cells decreased with increasing rH3N1 input 
MOI (Fig 3.1B). To determine whether these patterns could simply be explained by 
higher numbers of cells being infected with rH3N1 at higher rH3N1 input MOIs, we 
assessed how well two different models of super-infection fit the experimental data. The 
first model assumed that all rH3N1-infected cells had the same reduced probability of 
becoming infected with rH1N2 (input-independent). The second model assumed that the 
probability of being infected with rH1N2 decreased with cellular rH3N1 MOI (input-
dependent). Similar to the co-infection null model, both models assumed that cells fall 
into either a high or low susceptibility class. We fit each of these two models to the SIE 
data. The input-independent model underestimated the extent of rH1N2 infection to a 
greater extent than the input-dependent model (Fig 3.1B). The input-independent model 
further systematically underestimated the extent of double (H3+H1+) infection at low 
rH3N1 input MOI, while systematically overestimating these measurements at high 
rH3N1 input MOI (Fig 3.1B). In contrast, the input-dependent model was better able to 
reproduce the double (H3+H1+) infection measurements across all experimental MOIs 
(Fig 3.1B). As anticipated from these patterns, we found that the input-dependent model 
was significantly better supported by the data than the input-independent model. In Fig 
3.1C, we show the relationship between cellular input and susceptibility to superinfection 
predicted by this input-dependent model, indicating a rapid decline in susceptibility to 




These results demonstrate that the strength of SIE increases with the increase of primary 
infection MOI, which is in consistent with our previous finding that susceptibility to 
superinfection is inversely correlated with the cellular dosage of replication complexes 
delivered by incoming virions. Thus, the MOI-dependence of SIE may serve as a 
negative feedback loop that restricts the maximum number of virions that can 
successfully infect a given cell. 
 
SIE is largely independent of host innate immune response 
The host innate immune response serves as the first line of defense against viral infection. 
It is possible that the antiviral state induced by innate immune response to infection 
suppresses the subsequent infection. We hypothesized that SIE is mediated by host innate 
antiviral response triggered by the primary infection. We anticipated that there are 
multiple antiviral signaling pathways that contribute to SIE. 
 
To determine which antiviral pathway is involved in SIE, we compared SIE between 
wild-type cells and cells lacking expression of specific individual host factors involved in 
different antiviral pathways. We repeated superinfection with rH3N1 and rH1N2 viruses 
as described before at low MOI (<0.3 TCID50/cell) in wild-type and CRISPR knockout 
(KO) human foreskin fibroblasts (hFF) lacking expression of IRF3 (transcription factor 
of type I IFN), PKR (ISG that inhibits viral protein synthesis), STING (sensor of 
cytosolic DNA associated with viral infection)(Franz et al. 2018), MyD88 (adaptor 
protein involved in TLR signaling), and MAVS (activator of NF-κB and IRF3). 
Surprisingly, the level of SIE measured by the decrease in superinfection rate in 6-hr 
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group relative to 0-hr group were comparable between wild-type and most KO hFF, 
indicating expression of the host factors are not required for SIE (Fig 3.2A,B). The only 
group in which we observed a moderate decrease of SIE was the STING KO. We thus 
validated this result by repeating the experiment in A549 cells which is a more 
biologically relevant cell line. However, there was no difference in SIE between wild-
type and STING KO A549 cells (Fig 3.2C). Finally, we repeated the experiment in IFIT2 
KO HEK293 cells to test the effects of IFIT2, an ISG that is highly relevant to IAV 
infection(Zhou et al. 2013). Again, we observed no difference in SIE (Fig 3.2D). In these 
experiments, the hFF and A549 cells were gifted by Dr. Victor DeFillippis and the 
HEK293 cells were gifted by Dr. Andrew Mehle. 
 
These results indicate that SIE does not solely depend on expression of the host factors or 
the antiviral signaling pathways that we tested. Consistent with our previous finding that 
SIE is independent of type I IFN secretion, our data suggest that SIE is largely 
independent of host innate immune response.  
 
SIE cannot be fully explained by decrease in viral binding efficiency 
To better understand the mechanisms of SIE, we wanted to determine the viral replication 
step that is inhibited during superinfection. By determining when and where SIE actually 
occurs, we can focus on investigating the viral and host factors involved in that particular 
viral replication step. We set out to test whether SIE occurs at the beginning of viral life 
cycle, binding of virus particles to the host cell surface. Previously we have shown that 
68 
 
SIE is independent of viral NA activity, we thus hypothesized that SIE does not occur at 
the step of viral binding. 
 
Since the level of SIE is positively correlated with MOI of the primary infection (Fig 
3.1C), we amplified SIE to increase the chance of seeing any effects by repeating 
superinfection experiment described above with rH3N1 and rH1N2 viruses at high MOI 
(3 TCID50/cell). As expected, with a MOI of 3, over 95% of the superinfection in 6-hr 
group was blocked by the primary infection (Fig 3.3A). To determine whether this 
blockage occurred at the binding step, we measured rH1N2 titers in the inoculum before 
and after the 1-hr adsorption using RT-qPCR and calculated the titers of rH1N2 adsorbed 
to cell monolayers by subtracting titers of post-adsorption inoculum from pre-adsorption 
inoculum. As shown in Fig 3.3B, around 80% of rH1N2 adsorbed to cell monolayers in 
0-hr group where there was no SIE and around 60% of rH1N2 adsorbed in 6-hr group, 
indicating a 25% decrease in binding efficiency which is significantly lower than the 95% 
blockage in superinfection.  
 
Together, although our data showed that the binding efficiency is decreased in 6-hr 
delayed superinfection, it seems to be a minor contributor to SIE, suggesting the majority 
of SIE likely occurs post-binding.   
 
3.3 Discussion 
In this study, we first demonstrated that the primary infection MOI is positively 
correlated with the level of SIE which is in consistent with our previous findings. This 
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dose-dependent fashion indicates that the extent of cellular co-infection is a major 
determinant of viral replication and transmission. Under low MOI conditions where co-
infection is rare, most infected cells are infected by single semi-infectious particle and the 
average number of functional viral gene segments within each infected cell are relatively 
low. As a result, SIE remains less potent, so most infected cells can be complemented via 
superinfection. Under high MOI condition where co-infection is common, most infected 
cells contain more than one copy of viral genomes so that the SIE is highly activated, 
leaving infected cells refractory to superinfection. Clearly superinfection-mediated 
multiplicity reactivation under low MOI increases viral replicative potential, but what is 
the biological significance of inhibiting superinfection under high MOI remains unclear.  
 
While we showed that SIE is independent of multiple antiviral signaling pathways that 
have been shown to play crucial roles against IAV infection, it is still possible that SIE is 
mediated by combinations of more than one antiviral pathway we tested or by the 
pathways we didn’t test, such as activation of inflammasome. In addition, the host innate 
immune response is highly variable among infections of different IAV strains in different 
cell types. Thus, we cannot completely rule out the role of host antiviral mechanisms on 
SIE even if our data strongly suggest they are irrelevant. 
 
Interestingly, despite we previously showing that SIE is independent of NA activity, we 
still observed a 25% drop in viral binding efficiency in 6-hr delayed superinfection. 
Importantly, not all virus particles that bind to cell surface are going to be endocytosed. 
SIE can occur in any post-binding stage of viral replication cycle, including endocytosis, 
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membrane fusion, nuclear import and replication of viral genome. Images from high 
resolution microscopy on fluorescently labeled genomes of superinfecting virus showed 
that SIE occurs as early as 3 hours post-infection and a sizable number of viral genomes 
fail to make it to nucleus(Dou et al. 2017). Importantly, this study also revealed that viral 
genomes that entered the nucleus were not replicating, indicating SIE also occurs after 
nuclear import. Therefore, combining our results on viral binding, it is very likely that 
SIE results from the additive inhibitory effects on superinfecting viruses at multiple 
stages of viral replication cycle. To determine what percentages of superinfection are 
inhibited at each step of replication cycle, a time course study with single-molecule 
resolution microscopy is needed to more accurately localize and quantify the genomes 
from superinfecting viruses.  
 
To conclude, this study revealed that viral co-infection level is positively correlated with 
the strength of SIE and host innate antiviral response is likely not a major contributor to 
SIE. In addition, decrease in viral binding efficiency is a minor contributor to SIE, 
indicating majority of SIE occurs post binding. Altogether, our results shed new light on 
the mechanisms of SIE and provide insights on basic biology IAV infection. 
 
3.4 Materials and methods 
Cells 
Madin-Darby canine kidney (MDCK) and human embryonic kidney HEK293T (293T) 
cells were maintained in Gibco’s minimal essential medium (MEM) with GlutaMax (Life 
Technologies). Vero cells and human foreskin fibroblast (hFF) cells were maintained in 
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Dulbecco’s modified Eagle medium (Life Technologies). Human lung epithelial A549 
cells were maintained in Gibco’s F-12 medium (Life Technologies). MDCK and Vero 
cells were obtained from Jonathan Yewdell; wild-type and CRISPR KO hFF and A549 
cells were obtained from Victor DeFillippis; wild-type and CRISPR KO HEK293 cells 
were obtained from Andrew Mehle. All media were supplemented with 8.3% fetal bovine 
serum (Seradigm). Cells were grown at 37°C and 5% CO2. 
 
Viruses 
Recombinant rH3N1 and rH1N2 viruses were generated using 8-plasmid rescue systems. 
The rH3N1 virus is a reassortant with the HA segment from A/Udorn/72 (H3N2) and the 
other 7 segments from A/Puerto Rico/8/1934 (PR8). The rH1N2 virus is a reassortant 
with the NA segment from A/Udorn/72 (H3N2) and the other 7 segments from A/Puerto 
Rico/8/1934 (PR8). The PR8 clones differ from the published sequence (GenBank 
accession no. AF389115 to AF389122) at two positions: PB1 A549C (K175N) and HA 
A651C (I207L) (numbering from initiating Met). All viruses were rescued by transfecting 
subconfluent 293T cells with 500 ng of each of the appropriate reverse genetics plasmids 
using JetPRIME (Polyplus) according to the manufacturer’s instructions. Plaque isolates 
derived from rescue supernatants were amplified into seed stocks in MDCK cells. 
Working stocks were generated by infecting MDCK cells at a MOI of 0.0001 TCID50/cell 
with seed stock and collecting and clarifying supernatants at 48 hpi. All viral growth was 
carried out in MEM with 1 ug/ml trypsin treated with L-(tosylamido-2-phenyl) ethyl 
chloromethyl ketone (TPCK-treated trypsin; Worthington), 1 mM HEPES, and 100 ug/ml 
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gentamicin. The titers of the virus stocks were determined via standard 50% tissue culture 
infectious dose (TCID50) assay. 
 
Superinfection assay 
For the 6hr superinfection group in Fig 3.1, confluent MDCK cells in six-well plates were 
infected with rH3N1 virus at intended MOIs of 0.05, 0.25, 1, 2.5, and 10 TCID50/cell 
respectively at 4°C. 1 hour post-adsorption, remaining inoculum was collected, 
monolayers were washed with PBS and incubated in MEM + 8.3% FBS. At 6 hpi, 
monolayers were superinfected with rH1N2 at MOI=0.5 TCID50/cell at 4°C. One-hour 
post-adsorption, monolayers were washed with PBS and incubated in MEM + 8.3% FBS. 
At 9 hpi of rH3N1 (3 hpi of rH1N2), the media was changed to MEM with 50 mM 
HEPES and 20 mM NH4Cl to block spread of both viruses. For the 0hr co-infection 
group, cells were infected with a mixture of rH3N1 and rH1N2 at the same MOIs as in 
6hr superinfection group. At 3 hpi, 20 mM NH4Cl was added to block viral spread. For 
both 0hr and 6hr groups, at 19 hpi of rH3N1 (13 hpi of rH1N2), cell monolayers were 
trypsinized into single-cell suspensions and stained with Alexa Fluor 647-conjugated 
mouse anti-H3 MAb H14-A2 and Alexa Fluor 488-conjugated mouse anti-H1 mAb H28-
E23 (gifts of Dr. Jon Yewdell). After staining, cells were washed with PBS, run on a BD 
LSR II, and analyzed using FlowJo version 10.1 (Tree Star, Inc.). For superinfection in 
Fig 3.2, the MOI of both rH3N1 and rH1N2 were less than 0.3 TCID50/cell, whereas the 





Measurement of adsorbed virus titers by RT-qPCR 
To quantify the actual amount of rH3N1 and rH1N2 virus adsorbed to cell monolayers 
within the 1-h adsorption in Fig 3.1 and Fig 3.3, we quantified virus genome equivalents 
present in both pre- and post-adsorption inoculum by RT-qPCR and use pre-adsorption 
genome equivalents to minus post-adsorption genome equivalents. Specifically, viral 
RNA was isolated from viral supernatant with Zymo vRNA 96-well extraction kit (Zymo 
Research) according to manufacturer’s instructions, eluted with 30 uL RNase free water, 
and stored at −70°C. For cDNA synthesis, 5 uL vRNA, 0.5 uL 10 mM dNTP mix 
(Sigma-Aldrich), and 1.0 uL Uni12 (AGCAAAAGCAGG) were incubated at 65°C for 5 
minutes then transferred to ice for 2 minutes. 1 uL SUPERase In RNase inhibitor (20 
U/uL; Thermo Fisher Scientific) was added to each mixture and incubated on ice again 
for 2 minutes. 6.5 uL dH2O, 4 uL 5X First-Strand Buffer, 1 uL 100 mM DTT, and 1 uL 
SuperScript III RT (200 U/uL; Thermo Fisher Scientific) were added to each reaction and 
incubated at 55°C for 60 minutes and heat inactivated at 70°C for 15 minutes. Genome 
equivalents (GE) of rH3N1 were estimated by RT-qPCR of N1 gene segment (F-
AAATCAGAAAATAACAACCATTGGA, R- ATTCCCTATTTGCAATATTAGGCT) 
and GE of rH1N2 were estimated by RT-qPCR of H1 gene segment (F-
AAGGCAAACCTACTGGTCCTGTT, R-AATTGTTCGCATGGTAGCCTATAC). In 
duplicate for each sample, 10 uL Power SYBR Green PCR master mix (Thermo Fisher 
Scientific), 0.5 uL 10 uM forward and reverse primers, 8 uL dH2O, and 1 uL cDNA were 
added to 0.2 mL MicroAmp Optical 96-well reaction plate (Thermo Fisher Scientific). 
RT-qPCR was performed on the QuantStudio 3 (Thermo Fisher Scientific) platform and 
the cycling conditions were as follows: 95°C for 10 minutes, 40 cycles of 95°C for 15 
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seconds and 60°C for 60 seconds. The standard curves established with pDZ-N1 and 
pDZ-H1 plasmids were used to estimate GE/uL and then each sample was corrected for 
dilution factor to give a final GE/mL. 
 
Statistical modeling of superinfection exclusion 
The statistical modeling was performed by Dr. Katia Koelle using our experimental data. 
We first developed and parameterized an appropriate ‘null’ model, where both viruses are 
introduced simultaneously, and superinfection exclusion would not be anticipated. In this 
model, we assumed that cells differed in their susceptibility to viral infection. This 
assumption reflects our finding that viral particles are unlikely to be Poisson-distributed 
across cells. In our null model, we did not adopt a negative binomial model to implement 
the possibility of viral particle overdispersion, as we had earlier, because if both 
reassortant viruses were assumed to be distributed according to a negative binomial 
distribution, viral particles (together) would not be distributed according to a negative 
binomial distribution. We instead considered a model that implemented different cell 
susceptibility classes, which we found to better accommodate viral overdispersion of 
distinct viral strains. To maintain simplicity, we considered only two types of cells: cells 
that had high susceptibility to infection and cells that had low susceptibility to infection. 
We defined fraction y of the cell population to be in low susceptibility state; the 
remaining fraction (1 - y) we assumed was in a high susceptibility state. We let a 
fraction x of the viral population enter the low susceptibility state cells; the remaining 
fraction of the viral population (1-x) we assumed entered the high susceptibility state 
cells. Under this model, the MOI of specifically the low susceptibility class of cells is 
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given by (input MOI)*(x/y), and the MOI of specifically the high susceptibility class of 
cells is given by (input MOI)*(1 - x)/(1 - y). When x = y, the Poisson distribution 
assumption is recovered, and both classes of cells have the same input MOI. We fit this 
simple model to the co-infection data, estimating three parameters: the actual rH1N2 
MOI, and the fractions x and y. The parameter values, estimated using an RSS approach, 
are actual rH1N2 MOI = 1.86 (95% CI = [1.71,2.03]), x = 2.14e-4 (95% CI = [0.334e-4, 
13.8e-4]), and y = 0.0526 (95% CI = [0.0381,0.0725]). This parameterized model fit the 
experimental data well (Fig 3.1A). Since the parameter x was estimated to be close to 0, 
this model effectively implemented the zero-inflated Poisson model, which had slightly 
lower statistical support than the negative binomial distribution. 
 
To analyze the data from the superinfection experiment, we set as given the three 
parameter values and simple two-state susceptibility model structure derived from the 
fitting of the data from the simultaneous co-infection experiment described above. We 
then considered two distinct models to determine how cellular MOI may impact the rate 
of superinfection exclusion: an input-independent model and an input-dependent model. 
The input-independent model assumed that all infected cells had the same lower chance 
of being superinfected than previously uninfected cells. The parameter s quantified the 
extent of susceptibility of the previously infected cells (1 being full susceptibility). The 
input-dependent model instead assumed that cells that were infected with rH3N1 could 
experience different probabilities of superinfection exclusion. These different 
probabilities depended on a rH3N1 virus input, with, presumably, higher levels of rH3N1 
virus input corresponding to higher probabilities of superinfection exclusion. For the 
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input-dependent model, we specifically assumed a functional form given by ri, 
where i denotes rH3N1 virus input and 0 ≤ r ≤ 1. We estimated s for the input-
independent model to be 0.0361 (95% CI = [0.0227, 0.0576]) and r for the input-
dependent model to be 0.293 (95% CI = [0.214, 0.402]).  
 
To perform model selection, we used the Akaike Information Criterion (AIC). AIC based 
on RSS values is given by the equation: 2k + n ln(RSS) + constant, where k is the number 
of estimated parameters and n is the number of data points. Since AIC is a relative 
measure of information loss and the model with the lowest AIC has the most support, we 
calculated ∆AIC values to perform model selection by taking the difference between a 
given model and the model with the lowest AIC value. Based on AIC, the input-





























Figure 3.1 Cellular co-infection decreases the potential for superinfection. (A) MDCK 
cells were simultaneously co-infected with rH1N2 (at a constant MOI) and rH3N1 (at 
varying input MOIs shown; x-axis) under single cycle conditions; SIE would not be 
expected to occur during simultaneous co-infection. Plot shows the percentages of all 
cells infected with rH1N2 (H1+; includes co-infected cells; dark blue), all cells infected 
with rH3N1 (H3+; includes co-infected cells; red), and cells co-infected with both 
(H3+H1+; light blue), as determined by flow cytometry at 19 hpi. Solid lines indicate the 
two-susceptibility state null model fit to these data. (B) MDCK cells were infected with 
rH3N1 at varying input MOIs (x-axis) under single cycle conditions. 6 hours later, cells 
were superinfected with rH1N2 at an intended MOI of 0.5 TCID50/cell. Percentages of 
cells that were H1 + (including cells co-infected with rH3N1), H3+ (including cells co-
infected with rH1N2), and H3+H1+ were determined by flow cytometry at 19 hpi. Lines 
indicate statistical fits of the input-independent (solid) and input-dependent (dashed) 
models. (C) Visualization of the input-dependent model of superinfection susceptibility 
where the susceptibility of infected cells to superinfection is shown relative to the 




















Figure 3.2 SIE is largely independent of the expression of specific individual host factors 
involved in innate immune response. The wild-type hFF (A,B), A549 cells (C), HEK293 
cells (D), and their CRISPR KO cell lines lacking expression of indicated individual host 
factors were infected with rH3N1 virus and were simultaneously (0hr) or sequentially 
(6hr) infected with rH1N2 virus; all infections were performed at MOI<0.3 TCID50/cell. 
H1+ frequencies within H3+ cells following simultaneous or sequential infection in the 
indicated cell lines were measured as indicatives of superinfection rate. The values for 
both the 0-h and 6-h groups are shown as percentages of the mean values of the 0-h 
control group to clearly illustrate the percentages of reduction in cellular susceptibility to 











Figure 3.3 SIE cannot be fully explained by decrease in binding efficiency. (A) Vero 
cells were infected with rH3N1 virus and were simultaneously (0hr) or sequentially (6hr) 
infected with rH1N2 virus; all infections were performed at MOI=3 TCID50/cell. 
H1+ frequencies within H3+ cells following simultaneous or sequential infection in the 
indicated cell lines were measured as indicatives of superinfection rate. The values for 
both the 0-h and 6-h groups are shown as percentages of the mean values of the 0-h 
control group to clearly illustrate the percentages of reduction in cellular susceptibility to 
superinfection in the 6-h group. (B) The percentages of rH1N2 virus inoculum adsorbed 
to cell monolayers during 1-h adsorption were measured by RT-qPCR for both 0-h and 6-















CHAPTER 4: SINGLE CELL HETEROGENEITY IN IAV GENE EXPRESSION 
SHAPES INNATE ANTIVIRAL RESPONSE 
 
4.1 Introduction 
RNA virus populations typically contain an enormous amount of sequence diversity due 
to an absence of virally encoded proofreading activity(Andino and Domingo 2015). In 
some cases, this genetic diversity can significantly influence infection outcomes(Bordería 
et al. 2015; Domingo-Calap et al. 2019; Xiao et al. 2017). In addition, influenza A virus 
(IAV) also exhibits substantial heterogeneity in the gene expression patterns of individual 
virions(Brooke 2017). Most IAV virions are only capable of expressing variable, 
incomplete subsets of viral genes(Brooke et al. 2013). The production and gene 
expression patterns of these semi-infectious particles (SIPs) can vary significantly 
between IAV strains(Brooke et al. 2014). Altogether, the high degree of diversity within 
IAV populations means that patterns of viral gene expression can vary significantly 
between individual infected cells. 
 
Numerous studies have leveraged recent advances in single cell analysis methods to 
assess the extent of cellular heterogeneity present during infection by a variety of viruses, 
including IAV(Heldt et al. 2015; Russell, Trapnell, and Bloom 2018; Russell et al. 2019; 
Drayman et al. 2019; Guo et al. 2017; Ramos et al. 2019; Schulte and Andino 2014; 
Steuerman et al. 2018; Zanini et al. 2018; C. Wang et al. 2020). These studies connect to 
a larger body of work that has begun to explore single cell heterogeneity within different 
host cell populations and tissues(Lawson et al. 2018; Papalexi and Satija 2018; Stuart and 
Satija 2019).The extent to which IAV population diversity influences patterns of single 
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cell heterogeneity and the ways in which these patterns shape broader infection dynamics 
and outcomes remain poorly understood. 
 
Here, we query the combined viral and host transcriptomes from thousands of individual 
cells, each infected by a single virion. This high-resolution dissection of viral and host 
gene expression patterns reveals that the transcriptional responses of individual infected 
cells can be highly divergent, resulting from the interplay between underlying cellular 
heterogeneity and viral population diversity. Thus, the host response to IAV infection 
consists of a heterogenous assemblage of highly variable single cell responses. This 
approach also reveals critical differences in the interactions of H1N1 and H3N2 viruses 
with the host antiviral machinery at the single cell level and implicates heterogeneity in 
NS segment expression as a major driver of the innate antiviral response to IAV 
infection. Altogether, these results establish the interplay between viral and host cell 
heterogeneity as a critical determinant of cellular infection outcomes. 
 
4.2 Results 
Generation of viral and host transcriptional data from thousands of singly infected 
cells 
To assess the effects of viral population heterogeneity on the host response to infection, 
we examined the combined viral and host transcriptional profiles from thousands of 
single infected cells. To focus on the effects of viral heterogeneity, we wanted to remove 
the variability that could arise from variation in cellular MOI. To ensure that the vast 
majority of infected cells were each infected with a single virion, we infected A549 cells 
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with either the 2009 H1N1 pandemic strain A/California/07/2009 (Cal07), or the seasonal 
human H3N2 strain A/Perth/16/2009 (Perth09) at an MOI of 0.01, and blocked secondary 
spread in the culture through the addition of NH4Cl(Martin and Helenius 1991). This 
resulted in only a tiny fraction of cells being infected, so to obtain sufficient numbers of 
infected cells for our analysis, we enriched infected cells by sorting based on surface 
expression of HA and/or M2 (Fig 4.1A). This approach had the added benefit of allowing 
us to sort HA-M2- bystander cells from the same culture to assess the paracrine effects of 
infection. In parallel, we sorted a group of mock-infected cells as a control. 
 
We used the 10X Genomics Chromium platform to generate oligo-dT-primed single cell 
RNAseq libraries for mock, infected (HA+ and/or M2+), and bystander (HA-M2-) cells 
and sequenced them on an Illumina Novaseq. We demultiplexed the reads and mapped 
them to a customized hybrid reference containing both human and influenza 
sequences/annotation. Following quality control filtering, we had high quality combined 
viral and host transcriptomes from thousands of single virion-infected cells, as well as 
uninfected bystander and mock cells. Clustering of these three libraries by transcriptional 
similarity revealed that infected and uninfected cells largely clustered independently, as 
would be expected (Fig 4.1B,4.8). For Cal07 (but not Perth09), mock and bystander cells 
clustered independently, but it is possible this is due to a batch effects, as the mock and 
bystander cells came from different culture vessels. 
 
Although we sorted infected cells based on the presence of viral markers, it is possible 
that some uninfected cells were included within the infected cell libraries due to a 
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combination of cell sorting errors, library index hopping, or cross-contamination with 
mRNA released from dying cells. To identify the truly infected cells within the infected 
libraries, we examined the distributions of percentage of viral counts within each cell (Fig 
4.9). For cells in infected libraries of both Cal07 and Perth09, we observed clear bimodal 
distributions in the percentage of total viral counts. We assumed that cells within the 
lower peak (percentages of viral reads: < 1% for Cal07 and < 3% for Perth09) were 
actually uninfected. We calculated kernel density estimates on these distributions and 
used the first local minima to generate cutoff thresholds to differentiate truly-infected 
cells from uninfected cells (Fig 4.9A,C). Cells from infected libraries that fell below 
these thresholds clustered with the bystander cells, suggesting that these cells were truly 
uninfected (Fig 4.9B,D). We used this approach in subsequent analyses to define truly 
infected cells; however, it is possible that a small fraction of the cells we call as 
uninfected by these criteria are also truly infected yet exhibit very low levels of viral gene 
expression. 
 
Enormous single cell heterogeneity in viral gene expression patterns 
We first asked whether we observed the same degree of heterogeneity in viral gene 
expression between infected cells that has been reported previously(Brooke et al. 2013; 
Heldt et al. 2015; Russell, Trapnell, and Bloom 2018). We calculated the fraction of all 
transcripts within each cell that were viral in origin (Fig 4.2A). Similar to prior studies, 
total viral transcript levels ranged enormously between individual cells: from <1% up to 
~90%. Notably, this heterogeneity arose under conditions where both viral input (1 




Interestingly, the distributions for Cal07 and Perth09 were quite different, as Perth09-
infected cells tended to have a much higher fraction of viral transcript. This could be a 
reflection of differences in gene expression kinetics, or of differences in the relative 
capacities of the two viruses to exploit the host cell machinery necessary for viral gene 
expression. This pattern of extreme cell-to-cell heterogeneity was also observed for 
individual viral transcripts, again consistent with previous reports (Fig 4.2B,C)(Russell, 
Trapnell, and Bloom 2018). We examined the degree to which individual pairs of viral 
genes were correlated with each other within infected cells that expressed all viral genes 
(Fig 4.10,4.11). For Cal07, we found that most pairs of viral transcripts were fairly well 
correlated, with one obvious exception: the NS segment (Fig 4.2D). Expression levels of 
the individual viral genes were generally less well correlated during Perth09 infection, 
compared with Cal07, and expression of both the M and NS segments by Perth09 was 
especially poorly correlated with the other viral genes (Fig 4.2E). 
 
We also found that the expression distributions for individual viral genes were highly 
over-dispersed compared with a Poisson distribution (Fig 4.2F). The tails of the 
expression distributions for several viral genes were an order of magnitude longer than 
those of the top 10 most abundant host transcripts (Fig 4.2G), emphasizing that viral gene 






Significant heterogeneity in the host transcriptional response to infection 
We next asked whether the observed variation in viral gene expression levels was 
associated with variation in host cell transcription. To test this, we first clustered all 
infected cells based on their host transcription patterns. We identified multiple distinct 
transcriptional response groups to infection by either Cal07 or Perth09, demonstrating 
that there is not one standard transcriptional response to IAV infection and that a single 
cell type can simultaneously generate multiple distinct responses to the same virus 
population (Fig 4.3A,D). It should be noted that these cluster definitions are not absolute 
and that substantial heterogeneity in the normalized expression levels of individual host 
genes existed within individual clusters. 
 
We next asked whether the cell clustering patterns were correlated with levels of viral 
gene expression and/or cell cycle status. For Cal07, we did observe a relationship 
between overall viral gene expression levels and cluster structure, as the majority of cells 
with high levels of viral gene expression were concentrated in cluster 5 (Fig 4.3B). The 
clustering patterns of Cal07-infected cells also appeared to be partially influenced by cell 
cycle status, with cells in G2M phase disproportionately falling into cluster 0 (Fig 4.3C). 
While it is not surprising that cell cycle status would contribute to transcriptional 
heterogeneity during infection, these data highlight how little is known about how cell 
cycle status may influence the cellular response to infection. In contrast, we did not 
observe any clear relationships between viral gene expression levels, cell cycle status, 




We also observed the existence of multiple distinct clusters within mock cells (Fig 4.3G), 
raising the question of whether the observed heterogeneity in infected cells was simply a 
reflection of the intrinsic heterogeneity of the cell population prior to infection. In other 
words, does infection actually increase the overall heterogeneity in host gene expression 
patterns beyond that seen in mock cells? To quantify and compare heterogeneity in 
overall host transcription between the two cell populations, we calculated the multivariate 
homogeneity of dispersions for mock and infected cells using their host gene expression 
profiles (Fig 4.3H)(Anderson 2006). We found that infection significantly increased the 
overall single cell heterogeneity in host cell transcription patterns (p<10−15 by pairwise t 
test). Altogether, our data are consistent with a model in which the interaction between 
viral population heterogeneity and pre-existing host cell heterogeneity gives rise to 
multiple distinct transcriptional responses at the single cell level. 
 
Substantial heterogeneity in expression patterns of critical determinants of IAV 
infection outcome, including IFNs and ISGs 
To explore the specific transcriptional differences that distinguished different clusters of 
infected cells, we performed single cell differential gene expression analysis which 
allowed us to compare the expression of host transcripts between different clusters(W. 
Chen et al. 2018; Finak et al. 2015). This approach revealed that the induction of 
numerous host genes known or likely to be involved in shaping IAV infection outcome 
varied significantly between clusters (Fig 4.4A,C). Most strikingly, for Perth09 (but not 
Cal07), expression of type III IFNs and several ISGs were heavily concentrated within a 
single cluster, cluster 5 (Fig 4.4C). Beyond obvious factors like the IFNs and ISGS, both 
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viruses, exhibited highly heterogeneous expression patterns of numerous other host genes 
likely to influence infection outcomes. For example, per-cell expression levels of 
NEAT1, a long non-coding RNA (lncRNA) involved in inflammasome formation, 
regulation of cytokine and chemokine expression, and nuclear paraspeckle 
formation(Landeras-Bueno and Ortín 2016; Sasaki et al. 2009; F. Zhang et al. 2016, 1; P. 
Zhang et al. 2019), varied significantly between infected cell clusters for both viruses 
(Fig 4.4B,D). 
 
Hundreds of other host genes exhibited similarly heterogeneous patterns of expression 
between individual infected cells, though it must be pointed out that these measurements 
can be skewed somewhat by variation in viral RNA levels. Altogether, these data clearly 
demonstrate how numerous drivers of infection outcomes (not just IFNs) may be 
primarily expressed by limited subsets of infected cells. 
 
Many infected cells have undetectable levels of one or more viral transcripts 
The vast majority of IAV virions fail to express one or more viral genes, resulting in the 
expression of variable, incomplete subsets of viral gene products under low MOI 
conditions(Diefenbacher, Sun, and Brooke 2018). We asked whether this variation in 
functional viral gene content within individual cells contributes to the observed 
heterogeneity in host gene transcription. To assess the presence or absence of each 
individual viral gene within infected cells while avoiding false positives due to RNA 
cross-contamination, we used the same approach that we used to determine infection 
status of cells in infected libraries. Just as with overall viral gene expression, nearly all 
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individual viral genes exhibited clear bimodal patterns in the distributions of viral gene 
percentage within each cell on a log scale, suggestive of clear separations between 
positive and negative populations and allowing us to set cutoff thresholds based on the 
first local minima (Fig 4.12A,B). The only exceptions were PB2 and PA of Cal07. For 
these two genes that did not exhibit clear bimodal distribution, we set the cutoff 
thresholds at -1.5 (log10 scale) based on the distributions of polymerase gene expression 
in Perth09 and uninfected cells within the infected library of Cal07. It must be noted that 
while these cutoff thresholds represent our best effort to define the expression statuses of 
individual viral genes, they may not be perfectly accurate. 
 
Using these cutoffs, we found that the fractions of infected cells that failed to express 
detectable transcripts ranged from ~35% to ~5% for the individual viral gene segments 
(Fig 4.5A,C). It is highly likely that our method of enriching for infected cells by sorting 
based on high level HA and/or M2 expression significantly biased these results. 
Regardless, we still observed substantial numbers of infected cells that fail to express 
detectable levels of individual viral transcripts, with roughly half of all infected cells 
failing to express detectable levels of at least one viral gene (Fig 4.5B,D). We were 
surprised to see so many cells that lacked detectable levels of the polymerase transcripts 
because we expected that sorting infected cells based on surface protein expression would 
bias cell collection against cells that could not synthesize new polymerase complexes. 
One important caveat with our approach is that we assessed transcript levels at 16 hpi and 




The absence of individual viral genes has a significant effect on the host 
transcriptional response to infection 
We next asked how the expression status of individual viral genes influences the overall 
host response to infection to both Cal07 and Perth09. We grouped all infected cells into 
positive and negative populations based on the expression of each individual viral gene 
segment and compared host transcript expression between the two infected cell 
populations. For each viral gene, we generated a list of host transcripts that were reported 
as significantly different between positive and negative cells by both NBID and MAST 
tests. This approach allowed us to tease out the effects of individual viral gene segments 
from the more general effects of infection. 
 
We identified hundreds of host genes with expression levels that varied significantly 
based on the expression status of individual viral genes (Fig 4.13A,B). Closer 
examination revealed that many of these hits were found for multiple viral genes, 
suggesting that they may correlate with overall viral gene expression levels or co-
expression of multiple viral gene segments. When we focused on the host genes that only 
exhibited differential expression in association with the expression status of a single viral 







NS segment expression status is a major determinant of IFN and ISG induction by 
Perth09, but not Cal07 
We focused on the NS segment, as the NS-encoded NS1 protein plays a well-established, 
multi-functional role in manipulating the host cell environment and the anti-viral 
response and could thus serve as a positive control for our approach(Ayllon and García-
Sastre 2015; Hale et al. 2008; Krug 2015; Marc 2014). We found that approximately 4% 
of Cal07-infected cells and 9% of Perth09-infected cells had background or undetectable 
levels of NS segment transcript, and most of them came from cluster 5 with high viral 
transcript level which was in consistent with low correlation value between NS and other 
segments (Fig 4.6B,E). For Cal07, we observed over 300 host genes whose expression 
was uniquely influenced by NS. Notably, the expression of specific IFNs or ISGs was not 
significantly affected by NS expression status during Cal07 infection. In contrast, we did 
observe a significant reduction in SLFN5 expression frequency in infected cells that 
failed to express NS compared with those that did express NS (Fig 4.6C). SLFN5 is an 
interferon-stimulated gene (ISG) shown to negatively regulate STAT1-dependent anti-
viral gene transcription(Arslan et al. 2017, 5). These results both validate the utility of 
our approach and identify the suppressor of antiviral gene transcription SLFN5 as a novel 
host target of the NS gene segment during Cal07 infection. 
 
In contrast with Cal07 infection, NS segment expression status for Perth09 was 
significantly correlated with expression levels of numerous IFNs, ISGs, and other innate 
immune factors (Fig 4.6F). For example, the type III IFNs IFNL1 and IFNL2 were 
expressed by ~20% of Perth09-infected cells lacking detectable NS expression, but both 
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were only observed in ~2% of infected cells that did express NS. We also observed 
similar NS-dependent expression patterns for several ISGs (e.g. IFIT1, IFIT2, IFIT3, 
ISG15, ZC3HAV1, and OAS1), as well as the neutrophil-recruiting chemokine CXCL1. 
Thus, for Perth09 but not Cal07, single cell heterogeneity in NS segment expression 
status is a major determinant of the activation of the innate antiviral response. 
 
H1N1 and H3N2 strains can differ significantly in single cell patterns of IFN and 
ISG transcription 
Finally, we more broadly compared the activation of host innate anti-viral gene 
expression at the single cell level between Cal07 and Perth09. In Cal07-infected cells, 
expression of both type I and III IFNs were extremely rare, and only IFNL1 passed our 
quality control filter (detected in more than 4 cells) (Fig 4.7A)(Russell et al. 2019; Killip 
et al. 2017). For type I IFN (but probably not type III IFN), this could partially be a 
function of the relatively late timepoint that we examined, as IFNβ expression typically 
peaks earlier during infection(Österlund et al. 2012). Similarly, expression of multiple 
ISGs was also very rare in Cal07-infected cells, indicating a near-complete failure to 
initiate an innate anti-viral response. In bystander cells, both IFN and ISG expressions 
were also minimal, suggesting that the inhibition of IFN induction by Cal07 was 
sufficient to largely prevent paracrine ISG activation (Fig 4.7B). 
 
In Perth09-infected cells, IFNL1 (type III IFN) transcription was roughly 20-fold more 
frequent compared with Cal07, indicating a significant difference in the ability of the host 
to initiate an IFN response to infection by these two strains (Fig 4.7C). Consistent with 
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this, some (but not all) ISGs were clearly expressed more frequently in bystander and 
Perth09-infected cells compared with Cal07, suggesting that Perth09 is less able to 
prevent paracrine activation (Fig 4.7D). Altogether, these data reveal clear differences in 




The host response to infection arises from the combined responses of many individual 
cells, both infected and uninfected. To understand the factors that govern host responses 
at the tissue and organismal levels, it is critical to define patterns of variation in single 
cell infection responses. Here, we demonstrate that IAV infection gives rise to a 
heterogeneous collection of divergent transcriptional responses at the single cell level. 
Notably, this heterogeneity occurred within a single cell type, under conditions where 
per-cell viral input and infection timing were normalized. Single cell responses in 
vivo may be significantly more variable. By comparing patterns of viral gene expression 
at the single cell level between two distinct strains of human IAV, we demonstrate how 
viral population heterogeneity can be a major driver of innate immune activation, in a 
virus strain-specific manner. These data establish a clear role for viral heterogeneity in 
modulating the host response to infection and highlight the power of single cell 
approaches to reveal new determinants of viral infection outcomes. 
 
Variation in gene expression patterns between individual infected cells appears to arise 
from a combination of (1) genetic and genomic variation between individual virions, (2) 
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underlying heterogeneity within host cells, and (3) stochastic variation in infection 
processes. In line with previous reports of significant genetic and phenotypic 
heterogeneity within A459 and other transformed cell line populations, we observed 
substantial transcriptional heterogeneity between uninfected A549 cells that could not be 
simply explained by cell cycle status(Ben-David et al. 2018; Croce et al. 1999; Watanabe 
et al. 2002). As a result, virions that enter different cells establish infection within 
differing cellular environments that may be more or less supportive and primed for 
differing transcriptional responses to infection. This effect is likely enhanced by the 
stochastic variation inherent in different viral life cycle stages(Dou et al. 2017). 
 
Layered on top of this intrinsic cellular heterogeneity and stochasticity is the genetic and 
genomic heterogeneity characteristic of IAV populations(Brooke 2017). We and others 
have previously demonstrated that well-characterized viral modulators of host cell 
function such as NS1 and PA-X are not ubiquitously expressed during infection(Brooke 
et al. 2013; Russell, Trapnell, and Bloom 2018). Here, we show that this variability in 
viral gene expression between individual infected cells has clear consequences for the 
host cell transcriptional response. It is clear that future efforts to understand the role of 
critical viral proteins such as NS1 in shaping infection outcome will have to account for 
heterogeneity in single cell expression patterns. 
 
The comparison of Cal07 and Perth09 revealed clear commonalities and differences in 
single cell expression patterns between the two viruses that may have relevance for 
understanding differences in the apparent pathogenicity of different human H1N1 and 
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H3N2 viruses. The most obvious difference was seen in the activation of IFN and ISG 
transcription. In addition, while NS segment expression status significantly influenced the 
host response to both viruses, only Perth09 showed a clear relationship between NS 
levels and the activation of the host antiviral machinery. This finding is in line with 
previous studies that showed that (a) different human IAV strains differ in bulk induction 
of IFNβ, and (b) the 2009 pandemic H1N1 NS1 protein was less effective at suppressing 
transcription of human IFNs and ISGs compared with NS1 genes from other human IAV 
isolates(Hale et al. 2010; Hayman et al. 2006). While de novo NS segment transcription 
appeared to be largely dispensable for blocking IFN and ISG upregulation by Cal07 (at 
least under the conditions examined in this study), overall expression frequencies for 
select IFNs and ISGs were actually lower during Cal07 infection compared with Perth09, 
indicating that Cal07 is more effective at suppressing or evading IFN activation in A549 
cells. Yet, it remains an open question how overall viral gene expression level might 
influence the host innate antiviral response, given the clear differences we observed 
between the two viruses. Overall, our data make clear that there is still a lot that we do 
not understand about the interplay between viral gene expression patterns, viral genotype, 
and the host antiviral response. 
 
In this study, we took steps to eliminate two other sources of viral heterogeneity that are 
likely common during natural IAV infection. The first is presence of defective interfering 
particles (DIPs), which we minimized by generating our virus stocks under low MOI 
conditions, and subsequently verified (Fig 4.14). DIPs appear to be common within IAV 
populations, even in humans, and can have complicated effects on both viral and host 
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gene expression(Nayak, Chambers, and Akkina 1985; Russell et al. 2019; Alnaji et al. 
2019; Saira et al. 2013; Vasilijevic et al. 2017; Vignuzzi and López 2019). We would 
predict that the presence of DIPs would further increase overall heterogeneity between 
individual cell responses to the virus. It is worth noting that we could not reliably detect 
the presence of DIP-associated transcripts within our data due to the unavoidably 
incomplete coverage of the viral gene segments generated by our short-read 3’-enriched 
sequencing approach. The second likely source of additional heterogeneity that we 
excluded from this study is variability in the cellular MOI. We and others have 
demonstrated that cellular co-infection can be common in vivo(Brooke et al. 2014; 
Marshall et al. 2013; Fukuyama et al. 2015; Jacobs et al. 2019). This suggests that the 
number of viral genomes entering individual cells is likely quite variable. We recently 
showed that this variability in cellular MOI can have distinct phenotypic consequences, 
both for viral replication dynamics and for IFN induction. Altogether, it appears likely 
that the heterogeneity that we describe here underrepresents what would be observed in 
vivo. 
 
Our results extend our previous results and those of other groups in establishing the 
enormous amount of heterogeneity in viral gene expression that occurs at the single cell 
level, even under experimental conditions designed to minimize sources of 
variability(Dou et al. 2017; Brooke et al. 2013; Heldt et al. 2015; Russell, Trapnell, and 
Bloom 2018; Sjaastad et al. 2018). Critical phenotypes such as viral load dynamics, 
transmissibility, and pathogenicity must emerge from the collective output of 
heterogeneous populations of infected cells. This raises questions of how selection may 
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act upon patterns of viral heterogeneity to alter these emergent phenotypes and the extent 
to which these heterogeneity patterns are under viral genetic control. These questions are 
especially pertinent for segmented viruses like IAV but are relevant across diverse virus 
families. 
 
Altogether, our results help establish the importance of considering the roles of viral and 
host cell heterogeneity in influencing the pathogenesis of viral infections. Similar to the 
way that viral populations are now viewed, our data clearly establishes that the host 
response to infection should be seen as a heterogeneous assemblage of single cell 
responses that collectively give rise to the bulk phenotypes that are generally measured. 
This creates the potential for complex interactions between responding cell subsets and 
raises the question of how such a heterogeneous system is effectively regulated. It also 
raises the possibility that viral and host response dynamics may be disproportionately 
driven by small subsets of cells that are obscured during bulk analysis. Dissection of 
these diverse constituents is likely to reveal new mechanisms that govern the 
pathogenesis of influenza virus infection. 
 
4.4 Materials and methods 
Plasmids 
The A/California/04/09 and A/Perth/16/2009 reverse genetics plasmids were generous 
gifts from Drs. Jonathan Yewdell and Seema Lakdawala, respectively. Plasmids encoding 
A/California/07/09 were generated by introducing A660G and A335G substitutions into 
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HA and NP respectively, to match the amino acid sequences of A/California/07/09 HA 
and NP (NCBI accession numbers CY121680 and CY121683). 
 
Cells 
Madin-Darby canine kidney (MDCK) and human embryonic kidney HEK293T (293T) 
cells were maintained in Gibco’s minimal essential medium with GlutaMax (Life 
Technologies). Human lung epithelial A549 cells were maintained in Gibco’s F-12 
medium (Life Technologies). MDCK and A549 cells were obtained from Dr. Jonathan 
Yewdell; 293T cells were obtained from Dr. Joanna Shisler. All media were 




Recombinant A/California/07/09 (Cal07) and A/Perth/16/2009 (Perth09) viruses were 
rescued via the 8-plasmid reverse genetics approach. For the rescue of both viruses, sub-
confluent 293T cells were co-transfected with 500 ng of the following plasmids: 
pDZ::PB2, pDZ::PB1, pDZ::PA, pDZ::HA, pDZ::NP, pDZ::NA, pDZ::M, and pDZ::NS, 
using JetPrime (Polyplus) according to the manufacturer’s instructions. Plaque isolates 
derived from rescue supernatants were amplified into seed stocks in MDCK cells. 
Working stocks were generated by infecting MDCK cells at a MOI of 0.0001 TCID50/cell 
with seed stock and collecting and clarifying supernatants at 48 hpi. All viral growth was 
carried out in MEM with 1 ug/ml trypsin treated with L-(tosylamido-2-phenyl) ethyl 
chloromethyl ketone (TPCK-treated trypsin; Worthington), 1 mM HEPES, and 100 ug/ml 
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gentamicin. The titers of the virus stocks were determined via standard 50% tissue culture 
infectious dose (TCID50) assay. 
 
Viral infection and cell sorting for single cell RNAseq 
Confluent A549 cell monolayers in 3 T-25 flasks were infected with Cal07 (or Perth09) 
at MOI of 0.01 TCID50/cell for 1 h. At 1 hpi, monolayers were washed with phosphate-
buffered saline (PBS) and incubated in serum-containing F-12 medium. At 3 hpi, the 
medium was changed to MEM with 50 mM HEPES and 20 mM NH4Cl to block viral 
spread. At 16 hpi, monolayers were trypsinized and combined into single-cell suspension 
and washed with PBS. Cal07-infected cells were stained with Alexa Fluor 488-
conjugated mouse anti-HA monoclonal antibody (mAb) EM4-CO4 (gift from Dr. Patrick 
Wilson) and Alexa Fluor 647-conjugated mouse anti-M2 mAb O19 (gift from Dr. 
Jonathan Yewdell). Perth09-infected cells were first stained with human anti-HA stem 
antibody FI6 (Gift from Dr. Adrian McDermott) and then stained with Alexa Fluor 488-
conjugated donkey anti-human IgG (Jackson ImmunoResearch). After staining, cells 
were washed with PBS twice, and single live cells were sorted as “infected” or 
“bystander” populations based on the expression of HA and M2 on a BD FACS ARIA II 
sorter. Importantly, uninfected A549 cells from a separate flask were also trypsinized, 
stained, and sorted as “mock” population which served as a negative control. 
 
Single cell RNAseq cDNA library generation 
Sorted cell samples were counted and checked for viability on a BD20 cell counter (BIO-
RAD) before they were diluted to equivalent concentrations with an intended capture of 
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4000 cells/sample. Each individual sample was used to generate individually barcoded 
cDNA libraries using the 10x Chromium Single Cell 3’ platform (Pleasanton, CA) 
following the manufacturer’s protocol. The Chromium instrument separates single cells 
into Gel Bead Emulsions (GEMs) that facilitate the addition of cell-specific barcodes to 
all cDNAs generated during oligo-dT-primed reverse transcription. The experiment with 
Cal07 used V2 reagent and the experiment with Perth09 used V3 reagent (all steps 
followed the manufacturer’s protocol). 
 
Illumina Library preparation and sequencing 
Following ds-cDNA synthesis, individually barcoded libraries compatible with the 
Illumina chemistry were constructed. The libraries were sequenced on an Illumina 
NovaSeq 6000 using S4 flowcell for the experiment with Cal07 and S3 flowcell for the 
experiment with Perth09. Raw data can be found on the NCBI Gene Expression Omnibus 
under the GEO accession number GSE143167. 
 
Single cell RNAseq analysis 
The three Cal07-associated 10x Chromium Single Cell v2 libraries (Infected, Bystander, 
and Mock) were demultiplexed and reference mapped using Cell Ranger Count (version 
2.2) for alignment to a combined human+virus reference (human: hg38, version 1.2.0; 
Cal07: Genbank Accessions: CY121680-CY121687), and then combined using Cell 
Ranger Aggr. The three Perth09-associated 10x Chromium Single Cell v3 libraries 
(Infected, Bystander, and Mock) were processed and combined using Cell Ranger 
(version 3.1) for alignment to a combined human+virus reference (human: hg38, version 
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1.2.0; Perth09: Genbank Accessions: KJ609203.1- KJ609210.1). The resulting raw count 
matrix for each virus set was imported into an R pipeline using SimpleSingleCell(Lun, 
McCarthy, and Marioni 2016), where it was filtered for empty droplets(Lun et al. 2019). 
Cell cycle status was determined next by running the Cyclone tool in the scran R 
package(Lun, McCarthy, and Marioni 2016). Additional filtering was then performed on 
low feature cells (i.e. droplets removed if < 400 features/cell), low expressing features 
(i.e. features removed if < 4 cells/feature), and potential doublets (droplets removed if 
cell UMI counts > 2-fold of the median raw count number of host genes in cells of 3 
libraries combined). 
 
Overall cellular infection status (infected/uninfected) and individual virus gene 
presence/absence was determined by examining the distributions of percentage of viral 
counts within each cell on the log10 scale to magnify the differences at the low end. 
Thresholds for calling cells “not infected” overall and for individual viral gene 
presence/absence were set by calculating kernel density estimates on the distributions and 
finding the first local minima. For genes without clear bi-modal distributions (PB2 and 
PA of Cal07) the threshold was set to -1.5 (log10 scale), which was a consistent 
minimum in other low-expression viral genes and extremely close to the maximum value 
of PB2 and PA in uninfected cells within the Cal07 infected library. The filtered and 
annotated matrix was then imported into a Seurat pipeline for additional analysis and 
visualization(Stuart et al. 2019), including normalization using the SCTransform method 
(all 3 libraries together for the combined tSNE but then each library separately for 
individual tSNE)(Hafemeister and Satija 2019), differential gene expression analysis 
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using the MAST(Finak et al. 2015) and NBID tools(W. Chen et al. 2018), graph-based 
clustering of the cells(Macosko et al. 2015), and PCA/tSNE dimensional reduction 
visualization. 
 
Differential Gene Expression Analysis (DGE) for the Seurat clusters were performed by 
first sub-setting for ‘Infected’ status cells and then testing for each cluster versus all other 
clusters. The DGE gene list for each cluster consisted of genes with FDR < 0.01 in 
MAST test results generated from 10x Genomics Cell Ranger raw count matrix output. 
The DGE for missing individual virus genes were performed by first sub-setting the 
count matrices to contain only ‘Infected’ status cells and then using the individual virus 
gene status factors to test for cells with ‘Present’ versus ‘Absent’. The DGE gene list for 
each viral segment was produced by intersecting genes with FDR < 0.01 in both MAST 
and NBID test results to minimize false positives. 
 
All code used for single cell analysis, along with associated documentation, is available 
from: https://github.com/BROOKELAB/SingleCell 
 
Multivariate homogeneity of groups dispersions analysis 
In the analyses, each host gene represents a variable/coordinate and thus each cell can be 
seen as a point in the multivariate space. Multivariate homogeneity of groups dispersion 
analysis(Anderson 2006) was performed on log transformed host gene expressions of the 
two group of cells, i.e. mock cells and infected cells, using the betadisper function in the 
R package (http://www.R-project.org/) vegan. Distances between the points (i.e. cells) 
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and their respective group centroid in the principal coordinates were then used to test 
homogeneity of variances and calculate the p-value. Note that similar analyses were 
performed on linear host gene expression values and results remain the same, i.e. overall 
host gene expressions are significantly more heterogenous than those in mock cells. 
 
DVG detection in viral stocks 
Viral RNA was extracted from 140 ul of each viral stock tested using the QIAamp viral 
RNA kit (Qiagen) and eluted in 60 ul distilled water. For cDNA reactions, 3 ul of RNA 
was mixed with 1 ul (2 uM) MBTUni-12 primer (5-
ACGCGTGATCAGCAAAAGCAGG-3), 1 ul (10 mM) dNTPs, and 8 ul distilled water. 
The mixture was incubated for 5 min at 65°C and then placed on ice for 2 min. 
Subsequently, the mixture was removed from ice and the following were added: 1 ul 
SuperScript III (SSIII) RT (Invitrogen), 4 ul first-strand buffer, 1 ul DTT, and 1 ul 
RNase-in (Invitrogen). The reaction mixture was incubated at 45°C for 50 min, followed 
by a 15 min incubation at 70°C for inactivation. cDNA product (5 ul) was mixed with the 
following for PCR amplification: 2.5 ul (10 uM) MBTUni-12 primer, 2.5 ul (10 uM) 
MBTUni-13 primer (5-ACGCGTGATCAGTAGAAACAAGG-3), 0.5 ul Phusion 
polymerase (NEB), 10 ul high-fidelity buffer, 1 ul (10 mM) dNTPs, and 28.5 ul distilled 
water. The PCR protocol used was 98°C (30 s) followed by 25 cycles of 98°C (10 s), 
57°C (30 s), 72°C (90 s), and a terminal extension of 72°C (5 min). PCR products were 










Figure 4.1 Generation of viral and host transcriptional data for thousands of singly 
infected cells. (A) Schematic depicting our strategy for generating single cell RNAseq 
libraries from thousands of cells infected at low MOI. In brief, we infect A549 cells with 
Cal07 or Perth09 at MOI = 0.01 to ensure that infected cells are infected with a single 
virion. We then block secondary spread with NH4Cl treatment to make sure infection 
timing is uniform across all infected cells. Finally, we sort “infected” and “bystander” 
cells based on surface expression of HA and/or M2 and immediately generate single cell 
RNAseq libraries from these sorted cell populations using the 10X Chromium device. In 
parallel, mock cells are sorted and used as uninfected controls. (B) tSNE dimensionality 
reduction plot showing the extent of overlap between 3 indicated cell populations from 

























Figure 4.2 Enormous heterogeneity in viral gene expression patterns. (A) Distributions 
of Cal07 and Perth09-infected A549 cells, binned by the fraction of total cellular poly(A) 
RNA that is viral in origin. (B) Plots show the fraction of total poly(A) RNA per cell that 
maps to the indicated viral gene segment of Cal07. Each dot represents a single cell, cells 
with no detectable reads mapping to the indicated segment were arbitrarily assigned a 
value of 0.001 to show up on the log10 scale. (C) Same figure as (B) for 
Perth09. (D) R2 correlation values plotted as heat map for all pairwise comparisons of 
Cal07 viral transcripts within infected cells positive for all viral genes. (E) Same figure as 
(D) for Perth09. (F) Distribution of normalized Cal07-PB1-derived reads per cell 
(orange) compared with a Poisson distribution of equal mean (blue line) on a log-log 
scale. (G) Distributions of top 10 most abundant host transcripts (left panel) and Cal07 










Figure 4.3 Significant heterogeneity in the host transcriptional response to infection. 
(A) tSNE dimensionality reduction plot showing all Cal07-infected A549 cells clustered 
based on similarity of host transcription patterns. (B) Same tSNE plot of Cal07-infected 
cells shown in (A) with each cell colored by the percentage of total cellular poly(A) RNA 
that is viral in origin. (C) Same tSNE plot of Cal07-infected cells shown in (A) with each 
cell colored by predicted cell cycle stage, as determined by the Scran package. (D) Same 
figure as (A) for Perth09. (E) Same figure as (B) for Perth09. (F) Same figure as (C) for 
Perth09. (G) tSNE dimensionality reduction plot showing mock A549 cells from Cal07 
experiment clustered based on similarity of host transcriptional patterns. (H) Principle 
coordinate axes (PCoA) plot comparing the multivariate dispersions for mock (black) and 
Cal07-infected (red) A549 cells. The first two axes (PCoA 1 and PCoA 2) in the 






Figure 4.4 Substantial virus strain-specific variation in the expression patterns of critical 
determinants of IAV infection outcome. (A) Heat map showing differential expression of 
the top 10 characteristic host genes for each cluster of Cal07-infected cells (from Fig 3A). 
Individual cells are each represented by a column, grouped by cluster, with individual 
rows representing relative expression of the top 10 specific host transcripts most 
significantly (lowest p values) associated with each cluster. (B) Comparison of 
normalized per cell counts of NEAT1 between clusters of Cal07-infected cells shown in 
(A). (C) Same heat map as (A) for each cluster from Perth09-infected cells (From Fig 
3D), with the top 10 genes defining cluster 5 highlighted. (D) Comparison of normalized 



















Figure 4.5 Many infected cells have undetectable levels of one or more viral transcripts. 
(A) The percentage of all Cal07-infected cells called as positive for the indicated gene 
segments. (B) All Cal07-infected cells binned by the total number of viral gene segments 
that were called positive, with the actual numbers of cells in each group detailed 


















Figure 4.6 Dissection of the effects of individual viral gene expression on the host 
transcriptional response to infection. (A) The number of host transcripts for which 
expression levels significantly differ depending on whether the indicated Cal07 gene 
segment is present or not, according to both MAST and NBID (host genes that are 
differentially regulated by the expression status of more than one viral segment are 
excluded). (B) tSNE plot of all Cal07-infected A549 cells colored based on whether NS 
segment-derived transcripts are detected (Cyan) or not detected 
(Salmon). (C) Percentages of NS negative and NS positive Cal07-infected A549 cells that 
have detectable levels of SLFN5. (D) Same figure as (A) for Perth09. (E) Same figure as 
(B) for Perth09. (F) Percentages of NS negative and NS positive Perth09-infected A549 





















Figure 4.7 H1N1 and H3N2 strains differ significantly in single cell patterns of IFN and 
ISG transcription. (A) tSNE plots of all Cal07-infected A549 cells with cells that have 
detectable level of IFNL1 colored in red. (B) Histograms comparing distributions of per-
cell UMI counts in log10 scale for the indicated host transcripts across the three libraries 
(mock, bystander, and infected) for Cal07 experiment. Cells with zero count excluded to 
avoid dominating the y-scale. Vertical lines indicate cutoff thresholds of 3 UMI counts, 
with percentages of all cells (including cells with zero count) in each library above the 
























Figure 4.8 Viral and host transcriptional similarity in cells from Cal07 infection. tSNE 
dimensionality reduction plot showing the extent of overlap between 3 indicated cell 
























Figure 4.9 Determination of cutoff thresholds used to determine infection status. 
(A) Histograms comparing distributions of total viral mRNA percentages in log10 scale 
across the three libraries (mock, bystander, and infected) for Cal07 experiment. Vertical 
dash line indicates cutoff threshold determined by calculating kernel density estimates on 
the distribution of infected library and finding the first local minima. (B) Cells from each 
library clustered as in S1 Fig are shown separately, with uninfected cells (below 
threshold) colored in cyan and infected cells (above threshold) colored in 





Figure 4.10 All pairwise Cal07 viral gene correlation plots. Normalized per cell copy 
numbers for the indicated Cal07 genes plotted against each other. Data only show 














Figure 4.11 All pairwise Perth09 viral gene correlation plots. Normalized per cell copy 
numbers for the indicated Perth09 genes plotted against each other. Data only show 














Figure 4.12 Determination of cutoff thresholds used to determine or presence/absence of 
individual viral gene segments. (A) Histograms show the percentages of mRNA 
molecules derived from each Cal07 gene segment in log10 scale. Vertical dash lines 
indicate cutoff thresholds determined by calculating kernel density estimates on the 
distributions and finding the first local minima. For PB2 and PA that do not have clear bi-
modal distributions, the threshold was set to -1.5 (log10 scale), which was a consistent 
minimum in other low-expression viral genes and extremely close to the maximum value 


















Figure 4.13 Quantification of all differentially expressed host genes correlated with 
presence/absence of individual viral gene segments. (A) The number of host transcripts 
for which expression levels significantly differ depending on whether the indicated Cal07 
gene segment is present or not, according to both MAST and NBID (host genes that are 
differentially regulated by the expression status of more than one viral segment are 
































Figure 4.14 Comparison on DVGs content between validated viral stocks with low 
DVGs and viral stocks used in scRNAseq experiments. PCR products following 8-
segment whole-genome amplification from viral cDNAs of the pre-verified viral stocks 
(Cal07 LD and Perth09 LD have been shown to have minimum DVGs using NGS 
sequencing in articles published by the lab) and viral stocks used in scRNAseq 


























CHAPTER 5: CONCLUSIONS AND DISCUSSION 
 
The most majority of IAV particles are semi-infectious particles (SIPs) that express 
variable, incomplete subset of viral genes. During natural infection where virus particles 
within droplets are greatly outnumbered by the airway epithelial cells, the initial infection 
is likely under low MOI conditions. As a result, most infected cells are singly infected by 
SIPs that express different combinations of viral genes. Given that IAV requires 
expression of all viral genes to initiate productive infection, this incomplete, highly 
heterogeneous gene expression pattern at single particle level is likely the major reason 
why co-infection is commonly detected in vivo. To date, the biological significance and 
functional consequences of this viral gene expression heterogeneity remain largely 
unclear. In this thesis, we demonstrated that IAV gene expression heterogeneity regulates 
viral superinfection potential and host innate immune response.  
 
Using multicolor flow cytometry, we compared superinfection potential in cells 
expressing different combinations of viral genes and found that viral superinfection 
potential decreases with the increase of total number of actively replicating viral gene 
segments in infected cells. In addition, we found that this dose-dependent inhibitory 
effect on superinfection potential is dependent of viral replicase activity, but largely 
independent of cell types, activity of individual viral gene products, host innate antiviral 
response, and viral binding efficiency. It is clear that less potent superinfection exclusion 
(SIE) in SIPs promotes multiplicity reactivation and increases viral replicative potential. 




In future, more research is definitely needed to determine the mechanisms of SIE. 
Specifically, a combination of single molecule labeling technique and high-resolution 
microscopy would be ideal to quantify the viral genomes from superinfecting viruses that 
are trapped in endosome or cytoplasm and the viral genomes imported into nucleus that 
do or do not get replicated. To simplify the system, the viruses we used in superinfection 
assay shared similar genetic backgrounds. It would be interesting to study superinfection 
between different types of IAV or between IAV and other viruses. However, the concern 
is that the inhibition on superinfection could result from both SIE and viral interference 
between viruses that are genetically distant. Another caveat of our study is that we did not 
apply the superinfection assay to an animal model. Although it would be technically 
challenging, more study is needed to investigate superinfection in vivo and validate the 
findings in cell culture. 
 
The outcome of IAV infection depends heavily on the host innate immune response to 
infection. By pairing Fluorescence-Activated Cell Sorting (FACS) with single cell RNA-
seq (scRNAseq), we obtained combined host and viral transcriptomes of thousands of 
singly infected cells. We observed complex single cell patterns of viral gene expression 
and host transcriptional responses to infection. Further, we found that human H1N1 and 
H3N2 virus infections differ hugely in viral gene expression dynamics, type III IFN and 
ISG transcription at single cell level. Finally, we demonstrated that SIPs that fail to 
express NS in H3N2 infection but not H1N1 infection play a dominant role in inducing 




To verify the findings in this study, more replicates at different time points should be 
included to increase the statistical power and reproducibility. Moreover, it would be 
extremely meaningful to validate the strain-dependence in the induction of innate 
antiviral response in vivo. In this study, we revealed that the IFN transcription seems to 
be extremely rare and random under our experimental condition. In future, more study is 
definitely needed to identify novel factors (other than NS1 expression) that regulate IFN 
induction during IAV infection. Finally, host factors coming out of our differential gene 
expression (DGE) analysis whose expression are correlated with the expression status of 
individual viral gene should be experimentally verified. 
 
To summarize, we identified the biological consequences of IAV gene expression 
heterogeneity from two separate directions. First, we demonstrated that incomplete gene 
expression pattern in SIPs promotes co-infection by exerting less potent SIE, suggesting 
both multiplicity reactivation and reassortment can be regulated by viral gene expression 
heterogeneity. Second, we showed that host innate immune response can be 
disproportionately driven by small subsets of cells infected by SIPs, suggesting 
pathogenesis of IAV infection might be governed by viral gene expression heterogeneity 
at single cell level. Altogether, we illustrated that IAV gene expression heterogeneity and 
SIPs production have important functional consequences and are not merely the 
byproduct of infection. Further dissection on the intrinsic viral genomic diversity will 
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